{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:31:02Z","timestamp":1792791062963,"version":"4.5.0"},"reference-count":244,"publisher":"Bentham Science Publishers Ltd.","issue":"37","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Sulfonamides, with the general formula R-SO2NR1R2, have attracted great attention\nsince the early discovery of sulfonamide-containing antibacterial drugs. The combinations\nof certain sulfonamides and other drug molecules to form sulfonamide hybrids\nare being used to develop novel formulations with greater effectiveness and in a huge\nrange of therapeutic applications such as antimicrobial, antifungal, anti-inflammatory, antitubercular,\nantiviral, antidiabetic, antiproliferative, carbonic anhydrase inhibitor, antimalarial,\nanticancer and other medicinal agents. Part C of this review presents recent advances\nin designing and developing multicomponent sulfonamide hybrids containing more\nthan one biologically active heterocycle, such as coumarin, indole, pyridine, pyrimidine,\npyrazole, triazole, oxazole, oxadiazole, triazine, quinazoline, and thiadiazol. This review\naims to highlight the status of the hybridization technique in synthesizing biological and\ncomputational studies of novel sulfonamide hybrids that were designed and presented between\n2016 and 2020.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666221128142730","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T05:53:42Z","timestamp":1669701222000},"page":"4181-4255","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Recent Advances in Biological Active Sulfonamide based Hybrid\nCompounds Part C: Multicomponent Sulfonamide Hybrids"],"prefix":"10.2174","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-0547","authenticated-orcid":true,"given":"Reihane","family":"Ghomashi","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145,\nShahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-7298","authenticated-orcid":true,"given":"Shakila","family":"Ghomashi","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145,\nShahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-2728","authenticated-orcid":true,"given":"Hamidreza","family":"Aghaei","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box\n311-86145, Shahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samineh","family":"Massah","sequence":"additional","affiliation":[{"name":"School of Dentistry, Isfahan (Khorasgan) Branch, Islamic Azad University,\nIsfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8843-3190","authenticated-orcid":true,"given":"Ahmad Reza","family":"Massah","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box\n311-86145, Shahreza, Isfahan, Iran"},{"name":"Razi Chemistry Research Center (RCRC), Shahreza Branch, Islamic Azad University,\nIsfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"93","volume":"9","author":"Sunil R.","year":"2019","unstructured":"Sunil R.; Pal S.; Jayashree A.; Molecular hybridization-an emanating tool in drug design. Med Chem 2019,9(6),93-95","journal-title":"Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/ph4111450","volume":"4","author":"Bosquesi P.L.","year":"2011","unstructured":"Bosquesi P.L.; Melo T.R.F.; Vizioli E.O.; Santos J.L.; Chung M.C.; Anti-inflammatory drug design using a molecular hybridization approach. Pharmaceuticals (Basel) 2011,4(11),1450-1474","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/cmdc.201700113","volume":"12","author":"Fershtat L.L.","year":"2017","unstructured":"Fershtat L.L.; Makhova N.N.; Molecular hybridization tools in the development of furoxan\u2010based NO\u2010donor prodrugs. ChemMedChem 2017,12(9),622-638","journal-title":"ChemMedChem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","volume":"11","author":"B\u00e9rub\u00e9 G.","year":"2016","unstructured":"B\u00e9rub\u00e9 G.; An overview of molecular hybrids in drug discovery. Expert Opin Drug Discov 2016,11(3),281-305","journal-title":"Expert Opin Drug Discov"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.scitotenv.2018.06.016","volume":"640-641","author":"Chen J.","year":"2018","unstructured":"Chen J.; Xie S.; Overview of sulfonamide biodegradation and the relevant pathways and microorganisms. Sci Total Environ 2018,640-641,1465-1477","journal-title":"Sci Total Environ"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00044-019-02378-6","volume":"28","author":"Elgemeie G.H.","year":"2019","unstructured":"Elgemeie G.H.; Azzam R.A.; Elsayed R.E.; Sulfa drug analogs: new classes of N-sulfonyl aminated azines and their biological and preclinical importance in medicinal chemistry (2000-2018). Med Chem Res 2019,28(8),1099-1131","journal-title":"Med Chem Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ddr.21746","volume":"82","author":"Swain S.S.","year":"2021","unstructured":"Swain S.S.; Paidesetty S.K.; Padhy R.N.; Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria. Drug Dev Res 2021,82(2),149-166","journal-title":"Drug Dev Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/13543776.2018.1487400","volume":"28","author":"Gul\u00e7in \u0130.","year":"2018","unstructured":"Gul\u00e7in \u0130.; Taslimi P.; Sulfonamide inhibitors: a patent review 2013-present. Expert Opin Ther Pat 2018,28(7),541-549","journal-title":"Expert Opin Ther Pat"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"8166","DOI":"10.1039\/D1NJ00150G","volume":"45","year":"2021","unstructured":"Me\u015feli, T.; Do\u011fan, \u015e.D.; G\u00fcnd\u00fcz, M.G.; K\u00f6kbudak, Z.; Skaro Bogojevic, S.; Noonan, T.; Vojnovic, S.; Wolber, G.; Nikodinovic-Runic, J. Design, synthesis, antibacterial activity evaluation and molecular modeling studies of new sulfonamides containing a sulfathiazole moiety. New J Chem 2021,45(18),8166-8177","journal-title":"New J Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1021\/acs.jmedchem.8b00989","volume":"61","author":"Abdeen S.","year":"2018","unstructured":"Abdeen S.; Kunkle T.; Salim N.; Ray A.M.; Mammadova N.; Summers C.; Stevens M.; Ambrose A.J.; Park Y.; Schultz P.G.; Horwich A.L.; Hoang Q.Q.; Chapman E.; Johnson S.M.; Sulfonamido-2-arylbenzoxazole GroEL\/ES inhibitors as potent antibacterials against methicillin-resistant Staphylococcus aureus (MRSA). J Med Chem 2018,61(16),7345-7357","journal-title":"J Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1002\/slct.202101194","volume":"6","author":"Heiran R.","year":"2021","unstructured":"Heiran R.; Jarrahpour A.; Riazimontazer E.; Gholami A.; Troudi A.; Digiorgio C.; Brunel J.M.; Turos E.; Sulfonamide\u2010\u03b2\u2010lactam hybrids incorporating the piperazine moiety as potential antiinflammatory agent with promising antibacterial activity. ChemistrySelect 2021,6(21),5313-5319","journal-title":"ChemistrySelect"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.1080\/07391102.2021.1893818","volume":"40","author":"Devi K.","year":"2022","unstructured":"Devi K.; Awasthi P.; Isoleucine with secondary sulfonamide functionality as anticancer, antibacterial and antifungal agents. J Biomol Struct Dyn 2022,40(15),7052-7069","journal-title":"J Biomol Struct Dyn"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.dcmed.2021.12.004","volume":"4","author":"Shntaif A.H.","year":"2021","unstructured":"Shntaif A.H.; Khan S.; Tapadiya G.; Chettupalli A.; Saboo S.; Shaikh M.S.; Siddiqui F.; Amara R.R.; Rational drug design, synthesis, and biological evaluation of novel N-(2-arylaminophenyl)-2,3-diphenylquinoxaline-6-sulfona-mides as potential antimalarial, antifungal, and antibacterial agents. Digital Chinese Med 2021,4(4),290-304","journal-title":"Digital Chinese Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.5530\/ijper.55.4.214","volume":"55","author":"Salve M.T.","year":"2021","unstructured":"Salve M.T.; Jadhav S.B.; Synthesis, characterization and antidiabetic evaluation of sulfonamide in corporated with 1, 3, 4-oxadiazole derivatives. Indian J Pharmaceut Edu Res 2021,55(4),1145-1150","journal-title":"Indian J Pharmaceut Edu Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"104669","DOI":"10.1016\/j.bioorg.2021.104669","volume":"108","author":"Sayed A.M.","year":"2021","unstructured":"Sayed A.M.; Taher F.A.; Abdel-Samad M.R.K.; El-Gaby M.S.A.; El-Adl K.; Saleh N.M.; Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors. Bioorg Chem 2021,108,104669","journal-title":"Bioorg Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"113837","DOI":"10.1016\/j.ejmech.2021.113837","volume":"226","author":"Wan Y.","year":"2021","unstructured":"Wan Y.; Fang G.; Chen H.; Deng X.; Tang Z.; Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. Eur J Med Chem 2021,226,113837","journal-title":"Eur J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"112923","DOI":"10.1016\/j.ejmech.2020.112923","volume":"209","author":"Kumar S.","year":"2021","unstructured":"Kumar S.; Rulhania S.; Jaswal S.; Monga V.; Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. Eur J Med Chem 2021,209,112923","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1016\/j.bmc.2008.04.011","volume":"16","author":"Massah A.R.","year":"2008","unstructured":"Massah A.R.; Adibi H.; Khodarahmi R.; Abiri R.; Majnooni M.B.; Shahidi S.; Asadi B.; Mehrabi M.; Zolfigol M.A.; Synthesis, in vitro antibacterial and carbonic anhydrase II inhibitory activities of N-acylsulfonamides using silica sulfuric acid as an efficient catalyst under both solvent-free and heterogeneous conditions. Bioorg Med Chem 2008,16(10),5465-5472","journal-title":"Bioorg Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00706-007-0783-2","volume":"139","author":"Massah A.R.","year":"2008","unstructured":"Massah A.R.; Azadi D.; Aliyan H.; Momeni A.R.; Naghash H.J.; Kazemi F.; An efficient method for the synthesis of N-acylsulfonamides: One-Pot sulfonylation and acylation of primary arylamines under solvent-free conditions. Monatsh Chem 2008,139(3),233-240","journal-title":"Monatsh Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/molecules27051604","volume":"27","author":"Rubab L.","year":"2022","unstructured":"Rubab L.; Afroz S.; Ahmad S.; Hussain S.; Nawaz I.; Irfan A.; Batool F.; Kotwica-Mojzych K.; Mojzych M.; An update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents. Molecules 2022,27(5),1604","journal-title":"Molecules"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"132132","DOI":"10.1016\/j.matlet.2022.132132","volume":"317","author":"Ghomashi R.","year":"2022","unstructured":"Ghomashi R.; Rabiei M.; Ghomashi S.; Massah A.R.; Kolahdoozan M.; Hosseinnezhad M.; Ebrahimi-Kahrizsangi R.; Palevicius A.; Nasiri S.; Janusas G.; Synthesis and investigation of the theoretical and experimental optical properties of some novel azo pyrazole sulfonamide hybrids. Mater Lett 2022,317,132132","journal-title":"Mater Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1021\/jm301625s","volume":"56","author":"Tars K.","year":"2013","unstructured":"Tars K.; Vullo D.; Kazaks A.; Leitans J.; Lends A.; Grandane A.; Zalubovskis R.; Scozzafava A.; Supuran C.T.; Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013,56(1),293-300","journal-title":"J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1080\/00397910903318732","volume":"40","author":"Adibi H.","year":"2010","unstructured":"Adibi H.; Massah A.R.; Majnooni M.B.; Shahidi S.; Afshar M.; Abiri R.; Naghash H.J.; Synthesis, characterization, and antimicrobial evaluation of sulfonamides containing n-acyl moieties catalyzed by bismuth (III) salts under both solvent and solvent-free conditions. Synth Commun 2010,40(18),2753-2766","journal-title":"Synth Commun"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"17904","DOI":"10.1038\/s41598-020-74733-2","volume":"10","author":"Goljani H.","year":"2020","unstructured":"Goljani H.; Tavakkoli Z.; Sadatnabi A.; Masoudi-khoram M.; Nematollahi D.; A new electrochemical strategy for the synthesis of a new type of sulfonamide derivatives. Sci Rep 2020,10(1),17904","journal-title":"Sci Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1039\/c2ra20418e","volume":"2","author":"Massah A.R.","year":"2012","unstructured":"Massah A.R.; Sayadi S.; Ebrahimi S.; A green, mild and efficient one-pot method for the synthesis of sulfonamides from thiols and disulfides in water. RSC Advances 2012,2(16),6606-6616","journal-title":"RSC Advances"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.bmc.2019.02.050","volume":"27","author":"Giddens A.C.","year":"2019","unstructured":"Giddens A.C.; Gamage S.A.; Kendall J.D.; Lee W.J.; Baguley B.C.; Buchanan C.M.; Jamieson S.M.F.; Dickson J.M.J.; Shepherd P.R.; Denny W.A.; Rewcastle G.W.; Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474. Bioorg Med Chem 2019,27(8),1529-1545","journal-title":"Bioorg Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13065-018-0422-5","volume":"12","author":"Marciniec K.","year":"2018","unstructured":"Marciniec K.; Kurczab R.; Ksi\u0105\u017cek M.; B\u0119benek E.; Chrobak E.; Sata\u0142a G.; Bojarski A.J.; Kusz J.; Zajdel P.; Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT1A, 5-HT7, and D2 receptor ligands. Chem Cent J 2018,12(1),55","journal-title":"Chem Cent J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2174\/0929867033457647","volume":"10","author":"Scozzafava A.","year":"2003","unstructured":"Scozzafava A.; Owa T.; Mastrolorenzo A.; Supuran C.; Anticancer and antiviral sulfonamides. Curr Med Chem 2003,10(11),925-953","journal-title":"Curr Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.2174\/1871520618666180307142629","volume":"18","author":"Yurtta\u015f L.","year":"2018","unstructured":"Yurtta\u015f L.; \u00c7ift\u00e7i G.A.; New quinoline based sulfonamide derivatives: cytotoxic and apoptotic activity evaluation against pancreatic cancer cells. Anticancer Agents Med Chem 2018,18(8),1122-1130","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/157017806775789886","volume":"3","author":"Massah A.R.","year":"2006","unstructured":"Massah A.R.; Kazemi F.; Azadi D.; Farzaneh S.; Aliyan H.; Naghash H.; Momeni A.; A mild and chemoselective solvent-free method for the synthesis of N-aryl and Nalkylsulfonamides. Lett Org Chem 2006,3(3),235-241","journal-title":"Lett Org Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/1871520617666171103140749","volume":"18","author":"Rakesh K.P.","year":"2018","unstructured":"Rakesh K.P.; Wang S.M.; Leng J.; Ravindar L.; Asiri A.M.; Marwani H.M.; Qin H.L.; Recent development of sulfonyl or sulfonamide hybrids as potential anticancer agents: A key review. Anticancer Agents Med Chem 2018,18(4),488-505","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","volume":"162","author":"Zhao C.","year":"2019","unstructured":"Zhao C.; Rakesh K.P.; Ravidar L.; Fang W.Y.; Qin H.L.; Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review. Eur J Med Chem 2019,162,679-734","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/0929867329666220622153348","volume":"30","author":"Ghomashi R.","year":"2023","unstructured":"Ghomashi R.; Ghomashi S.; Aghaei H.; Massah A.R.; Recent advances in biological active sulfonamide based hybrid compounds part A: Two-component sulfonamide hybrids. Curr Med Chem 2023,30,407-480","journal-title":"Curr Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2174\/0929867329666220722143547","volume":"30","author":"Ghomashi S.","year":"2023","unstructured":"Ghomashi S.; Ghomashi R.; Aghaei H.; Massah A.R.; recent advances in biological active sulfonamide based hybrid compounds part B: Two-component sulfonamide hybrids. Curr Med Chem 2023,30,604-665","journal-title":"Curr Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00397911.2019.1647439","volume":"49","author":"Durgapal S.D.","year":"2019","unstructured":"Durgapal S.D.; Soman S.S.; Evaluation of novel coumarinproline sulfonamide hybrids as anticancer and antidiabetic agents. Synth Commun 2019,49(21),1-15","journal-title":"Synth Commun"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejmech.2016.08.062","volume":"124","author":"Kraljevi\u0107 T.G.","year":"2016","unstructured":"Kraljevi\u0107 T.G.; Harej A.; Sedi\u0107 M.; Paveli\u0107 S.K.; Stepani\u0107 V.; Drenjan\u010devi\u0107 D.; Talapko J.; Rai\u0107-Mali\u0107 S.; Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. Eur J Med Chem 2016,124,794-808","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.3390\/molecules25143251","volume":"25","author":"Alshibl H.M.","year":"2020","unstructured":"Alshibl H.M.; Al-Abdullah E.S.; Haiba M.E.; Alkahtani H.M.; Awad G.E.A.; Mahmoud A.H.; Ibrahim B.M.M.; Bari A.; Villinger A.; Synthesis and evaluation of new coumarin derivatives as antioxidant, antimicrobial, and antiinflammatory agents. Molecules 2020,25(14),3251","journal-title":"Molecules"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00706-017-2079-5","volume":"149","author":"Holiyachi M.","year":"2018","unstructured":"Holiyachi M.; Samundeeswari S.; Chougala B.M.; Naik N.S.; Madar J.; Shastri L.A.; Joshi S.D.; Dixit S.R.; Dodamani S.; Jalalpure S.; Sunagar V.A.; Design and synthesis of coumarin-imidazole hybrid and phenylimidazoloacrylates as potent antimicrobial and antiinflammatory agents. Monatsh Chem 2018,149(3),595-609","journal-title":"Monatsh Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"111702","DOI":"10.1016\/j.ejmech.2019.111702","volume":"183","author":"Zengin Kurt B.","year":"2019","unstructured":"Zengin Kurt B.; Sonmez F.; Ozturk D.; Akdemir A.; Angeli A.; Supuran C.T.; Synthesis of coumarinsulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies. Eur J Med Chem 2019,183,111702","journal-title":"Eur J Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1016\/j.bmcl.2016.06.037","volume":"26","author":"Lu X.Y.","year":"2016","unstructured":"Lu X.Y.; Wang Z.C.; Ren S.Z.; Shen F.Q.; Man R.J.; Zhu H.L.; Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis. Bioorg Med Chem Lett 2016,26(15),3491-3498","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1016\/j.bmcl.2017.07.020","volume":"27","author":"Shen F.Q.","year":"2017","unstructured":"Shen F.Q.; Wang Z.C.; Wu S.Y.; Ren S.Z.; Man R.J.; Wang B.Z.; Zhu H.L.; Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX. Bioorg Med Chem Lett 2017,27(16),3653-3660","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.7324\/JAPS.2017.70207","volume":"7","author":"El-Sawy E.R.","year":"2017","unstructured":"El-Sawy E.R.; Ebaid M.S.; Rady H.M.; Shalby A.B.; Ahmed K.M.; Abo-Salem H.M.; Synthesis and molecular docking of novel non-cytotoxic anti-angiogenic sulfonyl coumarin derivatives against hepatocellular carcinoma cells in vitro. J Appl Pharm Sci 2017,7,49-66","journal-title":"J Appl Pharm Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","volume":"24","author":"Chandak N.","year":"2016","unstructured":"Chandak N.; Ceruso M.; Supuran C.T.; Sharma P.K.; Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem 2016,24(13),2882-2886","journal-title":"Bioorg Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/14756366.2018.1477137","volume":"33","author":"Sabt A.","year":"2018","unstructured":"Sabt A.; Abdelhafez O.M.; El-Haggar R.S.; Madkour H.M.F.; Eldehna W.M.; El-Khrisy E.E.D.A.M.; Abdel-Rahman M.A.; Rashed L.A.; Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. J Enzyme Inhib Med Chem 2018,33(1),1095-1107","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3109\/14756366.2015.1077823","volume":"31","author":"Kurt B.Z.","year":"2016","unstructured":"Kurt B.Z.; S\u00f6nmez F.; Bilen \u00c7.; Ergun A.; Gen\u00e7er N.; Arslan O.; Kucukislamoglu M.; Synthesis, antioxidant and carbonic anhydrase I and II inhibitory activities of novel sulphonamide-substituted coumarylthiazole derivatives. J Enzyme Inhib Med Chem 2016,31(6),991-998","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ejmech.2016.10.020","volume":"124","author":"Ghorab M.M.","year":"2016","unstructured":"Ghorab M.M.; Alsaid M.S.; Al-Ansary G.H.; Abdel-Latif G.A.; Abou El Ella D.A.; Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers. Eur J Med Chem 2016,124,946-958","journal-title":"Eur J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioorg.2018.07.029","volume":"81","author":"Naaz F.","year":"2018","unstructured":"Naaz F.; Preeti Pallavi M.C.; Shafi S.; Mulakayala N.; Shahar Yar M.; Sampath Kumar H.M.; 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 and tubulin: Their anti-proliferative and anti-inflammatory activity. Bioorg Chem 2018,81,1-20","journal-title":"Bioorg Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/14756366.2018.1446432","volume":"33","author":"Awadallah F.M.","year":"2018","unstructured":"Awadallah F.M.; Bua S.; Mahmoud W.R.; Nada H.H.; Nocentini A.; Supuran C.T.; Inhibition studies on a panel of human carbonic anhydrases with N 1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails. J Enzyme Inhib Med Chem 2018,33(1),629-638","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00044-018-2271-0","volume":"28","author":"Feng Y.","year":"2019","unstructured":"Feng Y.; Teng X.; Gu J.; Yu B.; Luo Y.; Ye L.; Novel anti-cancer agents: design, synthesis, biological activity, molecular docking, and MD simulations of 2, 3, 4, 5-tetrahydro-1H-pyrido-[4,3-b]indole derivatives. Med Chem Res 2019,28(2),133-142","journal-title":"Med Chem Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1021\/acs.jmedchem.8b01550","volume":"62","author":"Luo G.","year":"2019","unstructured":"Luo G.; Chen L.; Easton A.; Newton A.; Bourin C.; Shields E.; Mosure K.; Soars M.G.; Knox R.J.; Matchett M.; Pieschl R.L.; Post-Munson D.J.; Wang S.; Herrington J.; Graef J.; Newberry K.; Sivarao D.V.; Senapati A.; Bristow L.J.; Meanwell N.A.; Thompson L.A.; Dzierba C.; Discovery of indole- and indazole-acylsulfonamides as potent and selective NaV1.7 inhibitors for the treatment of pain. J Med Chem 2019,62(2),831-856","journal-title":"J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1021\/acs.jmedchem.7b01285","volume":"61","author":"Boubia B.","year":"2018","unstructured":"Boubia B.; Poupardin O.; Barth M.; Binet J.; Peralba P.; Mounier L.; Jacquier E.; Gauthier E.; Lepais V.; Chatar M.; Ferry S.; Thourigny A.; Guillier F.; Llacer J.; Amaudrut J.; Dodey P.; Lacombe O.; Masson P.; Montalbetti C.; Wettstein G.; Luccarini J.M.; Legendre C.; Junien J.L.; Broqua P.; Design, synthesis, and evaluation of a novel series of indole sulfonamide peroxisome proliferator activated receptor (PPAR) \u03b1\/\u03b3\/\u03b4 triple activators: discovery of lanifibranor, a new antifibrotic clinical candidate. J Med Chem 2018,61(6),2246-2265","journal-title":"J Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1016\/j.bmcl.2016.08.018","volume":"26","author":"Greig I.R.","year":"2016","unstructured":"Greig I.R.; Baillie G.L.; Abdelrahman M.; Trembleau L.; Ross R.A.; Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators. Bioorg Med Chem Lett 2016,26(18),4403-4407","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4236\/ijoc.2020.102005","volume":"10","author":"Al-Romaizan A.N.","year":"2020","unstructured":"Al-Romaizan A.N.; Synthesis, characteristic and antimicrobial activity of some new spiro[indol-thiazolidon-2,4-diones] and bis(5-fluorospiro[indoline-3,2\u2032-thiazolidine]-2,4\u2032-dione) probes. Int J Org Chem (Irvine) 2020,10(2),77-87","journal-title":"Int J Org Chem (Irvine)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.1021\/acs.jmedchem.7b00839","volume":"60","author":"Bucki A.","year":"2017","unstructured":"Bucki A.; Marcinkowska M.; \u015aniecikowska J.; Wi\u0119ckowski K.; Paw\u0142owski M.; G\u0142uch-Lutwin M.; Grybo A.; Siwek A.; Pytka K.; Jastrz\u0119bska-Wi\u0119sek M.; Partyka A.; Weso\u0142owska A.; Mierzejewski P.; Ko\u0142aczkowski M.; Novel 3-(1, 2, 3, 6-tetrahydropyridin-4-yl)-1 H-indole-based multifunctional ligands with antipsychotic-like, mood-modulating, and procognitive activity. J Med Chem 2017,60(17),7483-7501","journal-title":"J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"103839","DOI":"10.1016\/j.bioorg.2020.103839","volume":"99","author":"Singh P.","year":"2020","unstructured":"Singh P.; Swain B.; Thacker P.S.; Sigalapalli D.K.; Purnachander Yadav P.; Angeli A.; Supuran C.T.; Arifuddin M.; Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids. Bioorg Chem 2020,99,103839","journal-title":"Bioorg Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejmech.2018.05.034","volume":"155","author":"Peerzada M.N.","year":"2018","unstructured":"Peerzada M.N.; Khan P.; Ahmad K.; Hassan M.I.; Azam A.; Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents. Eur J Med Chem 2018,155,13-23","journal-title":"Eur J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1021\/acsmedchemlett.6b00056","volume":"7","author":"Zajdel P.","year":"2016","unstructured":"Zajdel P.; Marciniec K.; Sata\u0142a G.; Canale V.; Kos T.; Partyka A.; Jastrz\u0119bska-Wi\u0119sek M.; Weso\u0142owska A.; Basi\u0144ska-Ziobro\u0144 A.; W\u00f3jcikowski J.; Daniel W.A.; Bojarski A.J.; Popik P.; N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor antagonists with procognitive and antidepressant-like properties. ACS Med Chem Lett 2016,7(6),618-622","journal-title":"ACS Med Chem Lett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1039\/C6MD00255B","volume":"7","author":"Man R.J.","year":"2016","unstructured":"Man R.J.; Tang D.J.; Lu X.Y.; Duan Y.T.; Tao X.X.; Yang M.R.; Wang L.L.; Wang B.Z.; Xu C.; Zhu H.L.; Synthesis and biological evaluation of novel indole derivatives containing sulfonamide scaffold as potential tubulin inhibitor. MedChemComm 2016,7(9),1759-1767","journal-title":"MedChemComm"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1700299","DOI":"10.1002\/ardp.201700299","volume":"351","author":"Roaiah H.M.","year":"2018","unstructured":"Roaiah H.M.; Ghannam I.A.Y.; Ali I.H.; El Kerdawy A.M.; Ali M.M.; Abbas S.E.S.; El-Nakkady S.S.; Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents. Arch Pharm (Weinheim) 2018,351(2),1700299","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.3390\/ijms20225592","volume":"20","author":"Halawa A.H.","year":"2019","unstructured":"Halawa A.H.; Eskandrani A.A.; Elgammal W.E.; Hassan S.M.; Hassan A.H.; Ebrahim H.Y.; Mehany A.B.M.; El-Agrody A.M.; Okasha R.M.; Rational design and synthesis of diverse pyrimidine molecules bearing sulfonamide moiety as novel ERK inhibitors. Int J Mol Sci 2019,20(22),5592","journal-title":"Int J Mol Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","volume":"8","author":"Nocentini A.","year":"2017","unstructured":"Nocentini A.; Bua S.; Lomelino C.L.; McKenna R.; Menicatti M.; Bartolucci G.; Tenci B.; Di Cesare Mannelli L.; Ghelardini C.; Gratteri P.; Supuran C.T.; Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases. ACS Med Chem Lett 2017,8(12),1314-1319","journal-title":"ACS Med Chem Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1016\/j.bmc.2016.07.049","volume":"24","author":"Silva T.B.","year":"2016","unstructured":"Silva T.B.; Bernardino A.M.R.; Ferreira M.L.G.; Rogerio K.R.; Carvalho L.J.M.; Boechat N.; Pinheiro L.C.S.; Design, synthesis and anti-P. falciparum activity of pyrazolopyridine-sulfonamide derivatives. Bioorg Med Chem 2016,24(18),4492-4498","journal-title":"Bioorg Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13065-017-0258-4","volume":"11","author":"Ghorab M.M.","year":"2017","unstructured":"Ghorab M.M.; Alsaid M.S.; El-Gaby M.S.A.; Elaasser M.M.; Nissan Y.M.; Antimicrobial and anticancer activity of some novel fluorinated thiourea derivatives carrying sulfonamide moieties: synthesis, biological evaluation and molecular docking. Chem Cent J 2017,11(1),32","journal-title":"Chem Cent J"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1021\/acsmedchemlett.7b00222","volume":"8","author":"Yang C.","year":"2017","unstructured":"Yang C.; Zhang X.; Wang Y.; Yang Y.; Liu X.; Deng M.; Jia Y.; Ling Y.; Meng L.; Zhou Y.; Discovery of a novel series of 7-azaindole scaffold derivatives as PI3K inhibitors with potent activity. ACS Med Chem Lett 2017,8(8),875-880","journal-title":"ACS Med Chem Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.3390\/molecules25194485","volume":"25","author":"Karpina V.R.","year":"2020","unstructured":"Karpina V.R.; Kovalenko S.S.; Kovalenko S.M.; Drushlyak O.G.; Bunyatyan N.D.; Georgiyants V.A.; Ivanov V.V.; Langer T.; Maes L.; A novel series of [1,2,4]triazolo[4,3-a]pyridine sulfonamides as potential antimalarial agents: In silico studies, synthesis and in vitro evaluation. Molecules 2020,25(19),4485","journal-title":"Molecules"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3390\/molecules22111926","volume":"22","year":"2017","unstructured":"Szafra\u0144ski, K.; S\u0142awi\u0144ski, J.; K\u0119dzia, A.; Kwapisz, E. Syntheses of novel 4-substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridine-3-sulfonamide derivatives with potential antifungal activity. Molecules 2017,22(11),1926","journal-title":"Molecules"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bioorg.2019.01.052","volume":"86","author":"Ghareb N.","year":"2019","unstructured":"Ghareb N.; El-Sayed N.M.; Abdelhameed R.; Yamada K.; Elgawish M.S.; Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors. Bioorg Chem 2019,86,322-338","journal-title":"Bioorg Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"103783","DOI":"10.1016\/j.bioorg.2020.103783","volume":"99","author":"Ullah S.","year":"2020","unstructured":"Ullah S.; El-Gamal M.I.; Zaib S.; Anbar H.S.; Zaraei S.O.; Sbenati R.M.; Pelletier J.; S\u00e9vigny J.; Oh C.H.; Iqbal J.; Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase\/phosphodiesterase. Bioorg Chem 2020,99,103783","journal-title":"Bioorg Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejmech.2016.08.060","volume":"124","author":"Ghorab M.M.","year":"2016","unstructured":"Ghorab M.M.; Alsaid M.S.; El-Gaby M.S.A.; Safwat N.A.; Elaasser M.M.; Soliman A.M.; Biological evaluation of some new N -(2,6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents. Eur J Med Chem 2016,124,299-310","journal-title":"Eur J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/jhet.3206","volume":"55","author":"Pawar C.D.","year":"2018","unstructured":"Pawar C.D.; Sarkate A.P.; Karnik K.S.; Shinde D.B.; Palladium catalyzed tricyclohexylphosphine ligand associated synthesis of N -(2-(pyridine-4-yl)-1 H -pyrrolo[3,2- c]-pyridin-6-yl-(substituted)-sulfonamide derivatives as antiproliferative agents. J Heterocycl Chem 2018,55(7),1695-1701","journal-title":"J Heterocycl Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1134\/S1068162016040087","volume":"42","author":"Ghorab M.M.","year":"2016","unstructured":"Ghorab M.M.; Alsaid M.S.; Novel 3-pyridinecarbonitriles incorporating sulfonamide moieties as anti-breast cancer agents. Russ J Bioorganic Chem 2016,42(4),441-448","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e1900291","DOI":"10.1002\/cbdv.201900291","volume":"16","author":"Gari Divya K.R.","year":"2019","unstructured":"Gari Divya K.R.; Lakshmi Teja G.; Yamini G.; Padmaja A.; Padmavathi V.; Synthesis of amido sulfonamido heteroaromatics under ultrasonication and their antimicrobial activity. Chem Biodivers 2019,16(11),e1900291","journal-title":"Chem Biodivers"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11030-018-9906-4","volume":"23","author":"Chandrasekhar M.","year":"2019","unstructured":"Chandrasekhar M.; Prasad G.S.; Venkataramaiah C.; Naga Raju C.; Seshaiah K.; Rajendra W.; Synthesis, spectral characterization, docking studies and biological activity of urea, thiourea, sulfonamide and carbamate derivatives of imatinib intermediate. Mol Divers 2019,23(3),723-738","journal-title":"Mol Divers"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1021\/acs.jmedchem.8b01556","volume":"61","author":"Barton N.","year":"2018","unstructured":"Barton N.; Convery M.; Cooper A.W.J.; Down K.; Hamblin J.N.; Inglis G.; Peace S.; Rowedder J.; Rowland P.; Taylor J.A.; Wellaway N.; Discovery of potent, efficient, and selective inhibitors of phosphoinositide 3-kinase \u03b4 through a deconstruction and regrowth approach. J Med Chem 2018,61(24),11061-11073","journal-title":"J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bmc.2017.12.025","volume":"26","author":"Lin S.","year":"2018","unstructured":"Lin S.; Wang C.; Ji M.; Wu D.; Lv Y.; Sheng L.; Han F.; Dong Y.; Zhang K.; Yang Y.; Li Y.; Chen X.; Xu H.; Discovery of new thienopyrimidine derivatives as potent and orally efficacious phosphoinositide 3-kinase inhibitors. Bioorg Med Chem 2018,26(3),637-646","journal-title":"Bioorg Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"127339","DOI":"10.1016\/j.bmcl.2020.127339","volume":"30","author":"Tan B.","year":"2020","unstructured":"Tan B.; Zhang X.; Quan X.; Zheng G.; Li X.; Zhao L.; Li W.; Li B.; Design, synthesis and biological activity evaluation of novel 4-((1-cyclopropyl-3-(tetrahydro-2Hpyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-\u03b2 (TGF-\u03b2) type I receptor inhibitors. Bioorg Med Chem Lett 2020,30(16),127339","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1021\/acsomega.9b03706","volume":"5","author":"Azzam R.A.","year":"2020","unstructured":"Azzam R.A.; Osman R.R.; Elgemeie G.H.; Efficient synthesis and docking studies of novel benzothiazole-based pyrimidinesulfonamide scaffolds as new antiviral agents and Hsp90\u03b1 inhibitors. ACS Omega 2020,5(3),1640-1655","journal-title":"ACS Omega"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jare.2020.07.008","volume":"26","author":"Li X.","year":"2020","unstructured":"Li X.; Wang D.; Lu G.; Liu K.; Zhang T.; Li S.; Mohamed O K.; Xue W.; Qian X.; Meng F.; Development of a novel thymidylate synthase (TS) inhibitor capable of upregulating P53 expression and inhibiting angiogenesis in NSCLC. J Adv Res 2020,26,95-110","journal-title":"J Adv Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1248\/cpb.c16-00291","volume":"64","author":"El-Ansary A.K.","year":"2016","unstructured":"El-Ansary A.K.; Kamal A.M.; Al-Ghorafi M.A.H.; Design, synthesis and biological evaluation of some 5-arylthieno[2,3-d]pyrimidines as potential anti-cancer agents. Chem Pharm Bull (Tokyo) 2016,64(8),1172-1180","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"112021","DOI":"10.1016\/j.ejmech.2019.112021","volume":"188","author":"Khalil O.M.","year":"2020","unstructured":"Khalil O.M.; Kamal A.M.; Bua S.; El Sayed Teba H.; Nissan Y.M.; Supuran C.T.; Pyrrolo and pyrrolopyrimidine sulfonamides act as cytotoxic agents in hypoxia via inhibition of transmembrane carbonic anhydrases. Eur J Med Chem 2020,188,112021","journal-title":"Eur J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"126982","DOI":"10.1016\/j.bmcl.2020.126982","volume":"30","author":"Sui Y.F.","year":"2020","unstructured":"Sui Y.F.; Li D.; Wang J.; Bheemanaboina R.R.Y.; Ansari M.F.; Gan L.L.; Zhou C.H.; Design and biological evaluation of a novel type of potential multi-targeting antimicrobial sulfanilamide hybrids in combination of pyrimidine and azoles. Bioorg Med Chem Lett 2020,30(6),126982","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"112019","DOI":"10.1016\/j.ejmech.2019.112019","volume":"189","author":"Said M.A.","year":"2020","unstructured":"Said M.A.; Eldehna W.M.; Nocentini A.; Fahim S.H.; Bonardi A.; Elgazar A.A.; Kry\u0161tof V.; Soliman D.H.; Abdel-Aziz H.A.; Gratteri P.; Abou-Seri S.M.; Supuran C.T.; Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. Eur J Med Chem 2020,189,112019","journal-title":"Eur J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/molecules21091156","volume":"21","author":"Hafez H.","year":"2016","unstructured":"Hafez H.; El-Gazzar A.R.; Synthesis and biological evaluation of N- pyrazolyl derivatives and pyrazolopyrimidine bearing a biologically active sulfonamide moiety as potential antimicrobial agent. Molecules 2016,21(9),1156","journal-title":"Molecules"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00044-018-2199-4","volume":"27","author":"Silveira F.F.","year":"2018","unstructured":"Silveira F.F.; Feitosa L.M.; Mafra J.C.M.; Ferreira M.L.G.; Rogerio K.R.; Carvalho L.J.M.; Boechat N.; Pinheiro L.C.S.; Synthesis and anti-Plasmodium falciparum evaluation of novel pyrazolopyrimidine derivatives. Med Chem Res 2018,27(8),1876-1884","journal-title":"Med Chem Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/cbdd.13429","volume":"93","author":"Kang D.","year":"2019","unstructured":"Kang D.; Wang Z.; Chen M.; Feng D.; Wu G.; Zhou Z.; Jing L.; Zuo X.; Jiang X.; Daelemans D.; De Clercq E.; Pannecouque C.; Zhan P.; Liu X.; Discovery of potent HIV \u20101 non\u2010nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solventexposed regions I. Chem Biol Drug Des 2019,93(4),430-437","journal-title":"Chem Biol Drug Des"},{"key":"ref=86","first-page":"907","volume":"58","author":"Butta R.","year":"2019","unstructured":"Butta R.; Ummadi N.; Adivireddy P.; Venkatapuram P.; Synthesis and antimicrobial activity of pyrimidinylsulfamoyl azolylbenzamides. Indian J Chem Sect B: Org Chem Incl Med Chem 2019,58,907-915","journal-title":"Indian J Chem Sect B: Org Chem Incl Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1600304","DOI":"10.1002\/ardp.201600304","volume":"350","author":"Rehman T.U.","year":"2017","unstructured":"Rehman T.U.; Khan I.U.; Ashraf M.; Tarazi H.; Riaz S.; Yar M.; An efficient synthesis of bi -aryl pyrimidine heterocycles: Potential new drug candidates to treat Alzheimer\u2019s disease. Arch Pharm (Weinheim) 2017,350(3-4),1600304","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1021\/acsmedchemlett.7b00361","volume":"8","author":"Kang D.","year":"2017","unstructured":"Kang D.; Ding X.; Wu G.; Huo Z.; Zhou Z.; Zhao T.; Feng D.; Wang Z.; Tian Y.; Daelemans D.; De Clercq E.; Pannecouque C.; Zhan P.; Liu X.; Discovery of thiophene [3, 2-d] pyrimidine derivatives as potent HIV-1 NNRTIs targeting the tolerant region I of NNIBP. ACS Med Chem Lett 2017,8(11),1188-1193","journal-title":"ACS Med Chem Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1248\/cpb.c19-00895","volume":"68","author":"Yamaguchi-Sasaki T.","year":"2020","unstructured":"Yamaguchi-Sasaki T.; Tamura Y.; Ogata Y.; Kawaguchi T.; Kurosaka J.; Sugaya Y.; Iwakiri K.; Busujima T.; Takahashi R.; Ueda-Yonemoto N.; Tanigawa E.; Abe-Kumasaka T.; Sugiyama H.; Kanuma K.; Design and synthesis of 2-(1-alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as new respiratory syncytial virus fusion protein inhibitors. Chem Pharm Bull (Tokyo) 2020,68(4),345-362","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1515\/acph-2017-0028","volume":"67","author":"Hafez H.N.","year":"2017","unstructured":"Hafez H.N.; Alsalamah S.A.; El-Gazzar A.R.B.A.; Synthesis of thiophene and N -substituted thieno[3,2- d] pyrimidine derivatives as potent antitumor and antibacterial agents. Acta Pharm 2017,67(3),275-292","journal-title":"Acta Pharm"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bmc.2016.01.018","volume":"24","author":"Barresi E.","year":"2016","unstructured":"Barresi E.; Salerno S.; Marini A.M.; Taliani S.; La Motta C.; Simorini F.; Da Settimo F.; Vullo D.; Supuran C.T.; Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII. Bioorg Med Chem 2016,24(4),921-927","journal-title":"Bioorg Med Chem"},{"key":"ref=92","first-page":"110","volume":"27","author":"Ghorab M.","year":"2016","unstructured":"Ghorab M.; Alsaid M.; Anticancer activity of some novel thieno [2, 3-d] pyrimidine derivatives. Biomed Res 2016,27,110-115","journal-title":"Biomed Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.bmc.2016.01.008","volume":"24","author":"Chen Y.","year":"2016","unstructured":"Chen Y.; Zhang L.; Yang C.; Han J.; Wang C.; Zheng C.; Zhou Y.; Lv J.; Song Y.; Zhu J.; Discovery of benzenesulfonamide derivatives as potent PI3K\/mTOR dual inhibitors with in vivo efficacies against hepatocellular carcinoma. Bioorg Med Chem 2016,24(5),957-966","journal-title":"Bioorg Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1021\/acs.jmedchem.0c00361","volume":"63","author":"Ramdas V.","year":"2020","unstructured":"Ramdas V.; Talwar R.; Kanoje V.; Loriya R.M.; Banerjee M.; Patil P.; Joshi A.A.; Datrange L.; Das A.K.; Walke D.S.; Kalhapure V.; Khan T.; Gote G.; Dhayagude U.; Deshpande S.; Shaikh J.; Chaure G.; Pal R.R.; Parkale S.; Suravase S.; Bhoskar S.; Gupta R.V.; Kalia A.; Yeshodharan R.; Azhar M.; Daler J.; Mali V.; Sharma G.; Kishore A.; Vyawahare R.; Agarwal G.; Pareek H.; Budhe S.; Nayak A.; Warude D.; Gupta P.K.; Joshi P.; Joshi S.; Darekar S.; Pandey D.; Wagh A.; Nigade P.B.; Mehta M.; Patil V.; Modi D.; Pawar S.; Verma M.; Singh M.; Das S.; Gundu J.; Nemmani K.; Bock M.G.; Sharma S.; Bakhle D.; Kamboj R.K.; Palle V.P.; Discovery of potent, selective, and state-dependent NaV1. 7 inhibitors with robust oral efficacy in pain models: Structure-activity relationship and optimization of chroman and indane aryl sulfonamides. J Med Chem 2020,63(11),6107-6133","journal-title":"J Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1002\/slct.201900799","volume":"4","author":"Katouah H.A.","year":"2019","unstructured":"Katouah H.A.; Gaffer H.E.; Synthesis and docking study of pyrimidine derivatives scaffold for anti-hypertension application. ChemistrySelect 2019,4(20),6250-6255","journal-title":"ChemistrySelect"},{"key":"ref=96","first-page":"168","volume":"6","author":"Variya H.H.","year":"2019","unstructured":"Variya H.H.; Panchal V.; Patel G.R.; Synthesis, antituberculosis and anti-bacterial activities of sulfadimethoxine bearing N-(2, 6-dimethoxypyrimidin-4-yl)-4-(4-oxo-2-(substituted) phenylthiazolidin-3yl) benzenesulfonamide. Int J Res Anal Rev 2019,6(2),168-180","journal-title":"Int J Res Anal Rev"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1002\/slct.201702785","volume":"3","author":"Bahekar S.P.","year":"2018","unstructured":"Bahekar S.P.; Chandak H.S.; Synthesis of Thiazolopyrimidines via Annulation of N -(4,6-Diaryl-2-thioxo-1,2,3,6-tetrahydropyrimidin-4-yl)phenyl)aryl-sulfonamides. ChemistrySelect 2018,3(9),2626-2630","journal-title":"ChemistrySelect"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"104350","DOI":"10.1016\/j.bioorg.2020.104350","volume":"104","author":"Saleh N.M.","year":"2020","unstructured":"Saleh N.M.; El-Gaby M.S.A.; El-Adl K.; Abd El-Sattar N.E.A.; Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors. Bioorg Chem 2020,104,104350","journal-title":"Bioorg Chem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1002\/jhet.4099","volume":"57","author":"Shinde R.R.","year":"2020","unstructured":"Shinde R.R.; Gaikwad D.; Farooqui M.; Synthesis and antimicrobial activity of 2\u2010(4\u2010(benzo[d]thiazol\u20105\u2010ylsulfonyl)piperazine\u20101\u2010yl)\u2010N\u2010substituted acetamide derivatives. J Heterocycl Chem 2020,57(11),3907-3917","journal-title":"J Heterocycl Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1021\/acsmedchemlett.8b00352","volume":"9","author":"Meleddu R.","year":"2018","unstructured":"Meleddu R.; Distinto S.; Cottiglia F.; Angius R.; Gaspari M.; Taverna D.; Melis C.; Angeli A.; Bianco G.; Deplano S.; Fois B.; Del Prete S.; Capasso C.; Alcaro S.; Ortuso F.; Yanez M.; Supuran C.T.; Maccioni E.; Tuning the dual inhibition of carbonic anhydrase and cyclooxygenase by dihydrothiazole benzensulfonamides. ACS Med Chem Lett 2018,9(10),1045-1050","journal-title":"ACS Med Chem Lett"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.bmc.2019.03.062","volume":"27","author":"Abdel-Maksoud M.S.","year":"2019","unstructured":"Abdel-Maksoud M.S.; Ammar U.M.; Oh C.H.; Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold. Bioorg Med Chem 2019,27(10),2041-2051","journal-title":"Bioorg Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.bmc.2016.05.016","volume":"24","author":"Abdel Gawad N.M.","year":"2016","unstructured":"Abdel Gawad N.M.; Amin N.H.; Elsaadi M.T.; Mohamed F.M.M.; Angeli A.; De Luca V.; Capasso C.; Supuran C.T.; Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines. Bioorg Med Chem 2016,24(13),3043-3051","journal-title":"Bioorg Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/molecules25163570","volume":"25","author":"Bhat M.A.","year":"2020","unstructured":"Bhat M.A.; Al-Omar M.A.; Naglah A.M.; Khan A.A.; Synthesis of novel sulfamethaoxazole 4-thiazolidinone hybrids and their biological evaluation. Molecules 2020,25(16),3570","journal-title":"Molecules"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1021\/acs.jmedchem.9b01961","volume":"63","author":"Sivaraman A.","year":"2020","unstructured":"Sivaraman A.; Kim D.G.; Bhattarai D.; Kim M.; Lee H.Y.; Lim S.; Kong J.; Goo J.; Shim S.; Lee S.; Suh Y.G.; Choi Y.; Kim S.; Lee K.; Synthesis and structureactivity relationships of arylsulfonamides as AIMP2-DX2 inhibitors for the development of a novel anticancer therapy. J Med Chem 2020,63(10),5139-5158","journal-title":"J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"26182","DOI":"10.1021\/acsomega.0c03773","volume":"5","author":"Azzam R.A.","year":"2020","unstructured":"Azzam R.A.; Elsayed R.E.; Elgemeie G.H.; Design and synthesis of a new class of pyridine-based Nsulfonamides exhibiting antiviral, antimicrobial, and enzyme inhibition characteristics. ACS Omega 2020,5(40),26182-26194","journal-title":"ACS Omega"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"30023","DOI":"10.1021\/acsomega.0c04424","volume":"5","author":"Azzam R.A.","year":"2020","unstructured":"Azzam R.A.; Elboshi H.A.; Elgemeie G.H.; Novel synthesis and antiviral evaluation of new benzothiazole-bearing N-sulfonamide 2-pyridone derivatives as USP7 enzyme inhibitors. ACS Omega 2020,5(46),30023-30036","journal-title":"ACS Omega"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.1021\/acsomega.0c00280","volume":"5","author":"Azzam R.A.","year":"2020","unstructured":"Azzam R.A.; Elsayed R.E.; Elgemeie G.H.; Design, synthesis, and antimicrobial evaluation of a new series of N-sulfonamide 2-pyridones as dual inhibitors of DHPS and DHFR enzymes. ACS Omega 2020,5(18),10401-10414","journal-title":"ACS Omega"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"128904","DOI":"10.1016\/j.molstruc.2020.128904","volume":"1222","author":"Aziz D.M.","year":"2020","unstructured":"Aziz D.M.; Azeez H.J.; Synthesis of new \u00df-lactam- N-(thiazol-2-yl)benzene sulfonamide hybrids: Their in vitro antimicrobial and in silico molecular docking studies. J Mol Struct 2020,1222,128904","journal-title":"J Mol Struct"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejmech.2017.11.023","volume":"143","author":"Li R.","year":"2018","unstructured":"Li R.; Ning X.; Zhou S.; Lin Z.; Wu X.; Chen H.; Bai X.; Wang X.; Ge Z.; Li R.; Yin Y.; Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators. Eur J Med Chem 2018,143,48-65","journal-title":"Eur J Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3109\/14756366.2015.1128425","volume":"31","author":"Husain A.","year":"2016","unstructured":"Husain A.; Madhesia D.; Rashid M.; Ahmad A.; Khan S.A.; Synthesis and in vivo diuretic activity of some new benzothiazole sulfonamides containing quinoxaline ring system. J Enzyme Inhib Med Chem 2016,31(6),1682-1689","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/jhet.3624","volume":"56","author":"Fadda A.A.","year":"2019","unstructured":"Fadda A.A.; Soliman N.N.; Bayoumy N.M.; Antimicrobial properties of some new synthesized benzothiazole linked carboxamide, acetohydrazide, and sulfonamide systems. J Heterocycl Chem 2019,56(9),2369-2378","journal-title":"J Heterocycl Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1039\/C7OB02386C","volume":"16","author":"Elsayed M.S.A.","year":"2018","unstructured":"Elsayed M.S.A.; Chang S.; Cushman M.; Ligand-free, palladacycle-facilitated Suzuki coupling of hindered 2-arylbenzothiazole derivatives yields potent and selective COX-2 inhibitors. Org Biomol Chem 2018,16(1),108-118","journal-title":"Org Biomol Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/14756366.2018.1426573","volume":"33","author":"Ugwu D.I.","year":"2018","unstructured":"Ugwu D.I.; Okoro U.C.; Ukoha P.O.; Gupta A.; Okafor S.N.; Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies. J Enzyme Inhib Med Chem 2018,33(1),405-415","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.molstruc.2019.04.048","volume":"1194","author":"Abd El-Gilil S.M.","year":"2019","unstructured":"Abd El-Gilil S.M.; Design, synthesis, molecular docking and biological screening of N-ethyl-N-methylbenzenesulfonamide derivatives as effective antimicrobial and antiproliferative agents. J Mol Struct 2019,1194,144-156","journal-title":"J Mol Struct"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"112745","DOI":"10.1016\/j.ejmech.2020.112745","volume":"207","author":"Alkhaldi A.A.M.","year":"2020","unstructured":"Alkhaldi A.A.M.; Al-Sanea M.M.; Nocentini A.; Eldehna W.M.; Elsayed Z.M.; Bonardi A.; Abo-Ashour M.F.; El-Damasy A.K.; Abdel-Maksoud M.S.; Al-Warhi T.; Gratteri P.; Abdel-Aziz H.A.; Supuran C.T.; El-Haggar R.; 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies. Eur J Med Chem 2020,207,112745","journal-title":"Eur J Med Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1007\/s42452-020-03726-7","volume":"2","author":"Majalakere K.","year":"2020","unstructured":"Majalakere K.; Kunhana S.B.; Rao S.; Kalal B.S.; Badiadka N.; Sanjeev G.; Holla B.S.; Studies on imidazo[2,1-b][1,3]benzothiazole derivatives as new radiosensitizers. SN Appl Sci 2020,2(11),1902","journal-title":"SN Appl Sci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1016\/j.bmc.2017.08.012","volume":"25","author":"Wu Y.J.","year":"2017","unstructured":"Wu Y.J.; Guernon J.; McClure A.; Luo G.; Rajamani R.; Ng A.; Easton A.; Newton A.; Bourin C.; Parker D.; Mosure K.; Barnaby O.; Soars M.G.; Knox R.J.; Matchett M.; Pieschl R.; Herrington J.; Chen P.; Sivarao D.V.; Bristow L.J.; Meanwell N.A.; Bronson J.; Olson R.; Thompson L.A.; Dzierba C.; Discovery of nonzwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation. Bioorg Med Chem 2017,25(20),5490-5505","journal-title":"Bioorg Med Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/jhet.3634","volume":"56","author":"Rajeswari T.","year":"2019","unstructured":"Rajeswari T.; Rekha T.; Dinneswara Reddy G.; Padmaja A.; Padmavathi V.; Synthesis and antibacterial activity of benzazolyl azolyl sulfamoyl acetamides. J Heterocycl Chem 2019,56(9),2449-2459","journal-title":"J Heterocycl Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/metabo10040136","volume":"10","author":"Manasa K.L.","year":"2020","unstructured":"Manasa K.L.; Pujitha S.; Sethi A.; Arifuddin M.; Alvala M.; Angeli A.; Supuran C.T.; Synthesis and biological evaluation of imidazo [2, 1-b] thiazole based sulfonyl piperazines as novel carbonic anhydrase II inhibitors. Metabolites 2020,10(4),136","journal-title":"Metabolites"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4236\/ijoc.2015.53018","volume":"5","author":"Bashandy M.S.","year":"2015","unstructured":"Bashandy M.S.; 1-(4-(pyrrolidin-1-ylsulfonyl) phenyl) ethanone in heterocyclic synthesis: synthesis, molecular docking and anti-human liver cancer evaluation of novel sulfonamides incorporating thiazole, imidazo [1, 2-a] pyridine, imidazo [2, 1-c][1, 2, 4] triazole, imidazo [2, 1-b] thiazole, 1, 3, 4-thiadiazine and 1, 4-thiazine moieties. Int J Org Chem (Irvine) 2015,5(3),166-190","journal-title":"Int J Org Chem (Irvine)"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1016\/j.arabjc.2020.03.014","volume":"13","author":"Hussein E.M.","year":"2020","unstructured":"Hussein E.M.; Al-Rooqi M.M.; Elkhawaga A.A.; Ahmed S.A.; Tailoring of novel biologically active molecules based on N-substituted sulfonamides bearing thiazole moiety exhibiting unique multi-addressable biological potentials. Arab J Chem 2020,13(5),5345-5362","journal-title":"Arab J Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"e0134556","DOI":"10.1371\/journal.pone.0134556","volume":"10","author":"Wang L.","year":"2015","unstructured":"Wang L.; Kofler M.; Brosch G.; Melesina J.; Sippl W.; Martinez E.D.; Easmon J.; 2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic acids as novel selective histone deacetylase-6 inhibitors with antiproliferative activity. PLoS One 2015,10(12),e0134556","journal-title":"PLoS One"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1016\/j.bmcl.2018.08.028","volume":"28","author":"Tsagris D.J.","year":"2018","unstructured":"Tsagris D.J.; Birchall K.; Bouloc N.; Large J.M.; Merritt A.; Smiljanic-Hurley E.; Wheldon M.; Ansell K.H.; Kettleborough C.; Whalley D.; Stewart L.B.; Bowyer P.W.; Baker D.A.; Osborne S.A.; Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG). Bioorg Med Chem Lett 2018,28(19),3168-3173","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.1021\/acs.jmedchem.0c00916","volume":"63","author":"Rai G.","year":"2020","unstructured":"Rai G.; Urban D.J.; Mott B.T.; Hu X.; Yang S.M.; Benavides G.A.; Johnson M.S.; Squadrito G.L.; Brimacombe K.R.; Lee T.D.; Cheff D.M.; Zhu H.; Henderson M.J.; Pohida K.; Sulikowski G.A.; Dranow D.M.; Kabir M.; Shah P.; Padilha E.; Tao D.; Fang Y.; Christov P.P.; Kim K.; Jana S.; Muttil P.; Anderson T.; Kunda N.K.; Hathaway H.J.; Kusewitt D.F.; Oshima N.; Cherukuri M.; Davies D.R.; Norenberg J.P.; Sklar L.A.; Moore W.J.; Dang C.V.; Stott G.M.; Neckers L.; Flint A.J.; Darley-Usmar V.M.; Simeonov A.; Waterson A.G.; Jadhav A.; Hall M.D.; Maloney D.J.; Pyrazole-based lactate dehydrogenase inhibitors with optimized cell activity and pharmacokinetic properties. J Med Chem 2020,63(19),10984-11011","journal-title":"J Med Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bioorg.2019.03.076","volume":"87","author":"Afifi O.S.","year":"2019","unstructured":"Afifi O.S.; Shaaban O.G.; Abd El Razik H.A.; Shams El-Dine S.E.D.A.; Ashour F.A.; El-Tombary A.A.; Abu-Serie M.M.; Synthesis and biological evaluation of purinepyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential. Bioorg Chem 2019,87,821-837","journal-title":"Bioorg Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00706-015-1549-x","volume":"147","author":"Ashour H.M.A.","year":"2016","unstructured":"Ashour H.M.A.; El-Ashmawy I.M.; Bayad A.E.; Synthesis and pharmacological evaluation of new pyrazolyl benzenesulfonamides linked to polysubstituted pyrazoles and thiazolidinones as anti-inflammatory and analgesic agents. Monatsh Chem 2016,147(3),605-618","journal-title":"Monatsh Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1021\/acs.jmedchem.7b00598","volume":"60","author":"Swain N.A.","year":"2017","unstructured":"Swain N.A.; Batchelor D.; Beaudoin S.; Bechle B.M.; Bradley P.A.; Brown A.D.; Brown B.; Butcher K.J.; Butt R.P.; Chapman M.L.; Denton S.; Ellis D.; Galan S.R.G.; Gaulier S.M.; Greener B.S.; de Groot M.J.; Glossop M.S.; Gurrell I.K.; Hannam J.; Johnson M.S.; Lin Z.; Markworth C.J.; Marron B.E.; Millan D.S.; Nakagawa S.; Pike A.; Printzenhoff D.; Rawson D.J.; Ransley S.J.; Reister S.M.; Sasaki K.; Storer R.I.; Stupple P.A.; West C.W.; Discovery of clinical candidate 4-[2-(5-amino-1Hpyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of NaV1.7. J Med Chem 2017,60(16),7029-7042","journal-title":"J Med Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bioorg.2017.11.010","volume":"76","author":"Naim M.J.","year":"2018","unstructured":"Naim M.J.; Alam O.; Alam M.J.; Hassan M.Q.; Siddiqui N.; Naidu V.G.M.; Alam M.I.; Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents. Bioorg Chem 2018,76,98-112","journal-title":"Bioorg Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1021\/acs.jmedchem.7b00162","volume":"60","author":"Hunt H.J.","year":"2017","unstructured":"Hunt H.J.; Belanoff J.K.; Walters I.; Gourdet B.; Thomas J.; Barton N.; Unitt J.; Phillips T.; Swift D.; Eaton E.; Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1 H -pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1 H -pyrazolo[3,4- g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT-125134): A Selective Glucocorticoid Receptor (GR) Antagonist J Med Chem 2017,60(8),3405-3421","journal-title":"Antagonist J Med Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/14756366.2018.1530225","volume":"34","author":"Abdel-Maksoud M.S.","year":"2019","unstructured":"Abdel-Maksoud M.S.; El-Gamal M.I.; Gamal El-Din M.M.; Oh C.H.; Design, synthesis, in vitro anticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety. J Enzyme Inhib Med Chem 2019,34(1),97-109","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1021\/acs.jmedchem.7b00941","volume":"60","author":"Rai G.","year":"2017","unstructured":"Rai G.; Brimacombe K.R.; Mott B.T.; Urban D.J.; Hu X.; Yang S.M.; Lee T.D.; Cheff D.M.; Kouznetsova J.; Benavides G.A.; Pohida K.; Kuenstner E.J.; Luci D.K.; Lukacs C.M.; Davies D.R.; Dranow D.M.; Zhu H.; Sulikowski G.; Moore W.J.; Stott G.M.; Flint A.J.; Hall M.D.; Darley-Usmar V.M.; Neckers L.M.; Dang C.V.; Waterson A.G.; Simeonov A.; Jadhav A.; Maloney D.J.; Discovery and optimization of potent, Cell-active pyrazolebased inhibitors of lactate dehydrogenase (LDH). J Med Chem 2017,60(22),9184-9204","journal-title":"J Med Chem"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1007\/s11164-018-3396-y","volume":"44","author":"Shingare R.M.","year":"2018","unstructured":"Shingare R.M.; Patil Y.S.; Sangshetti J.N.; Patil R.B.; Rajani D.P.; Rajani S.D.; Madje B.R.; Benzene sulfonamide pyrazole thio-oxadiazole hybrid as potential antimicrobial and antitubercular agents. Res Chem Intermed 2018,44(7),4437-4453","journal-title":"Res Chem Intermed"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/cbdd.13149","volume":"91","author":"Yamali C.","year":"2018","unstructured":"Yamali C.; Gul H.I.; Ece A.; Taslimi P.; Gulcin I.; Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1 H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes. Chem Biol Drug Des 2018,91(4),854-866","journal-title":"Chem Biol Drug Des"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"103110","DOI":"10.1016\/j.bioorg.2019.103110","volume":"91","author":"Mustafa G.","year":"2019","unstructured":"Mustafa G.; Angeli A.; Zia-ur-Rehman M.; Akbar N.; Ishtiaq S.; Supuran C.T.; An efficient method for the synthesis of novel derivatives 4-{5-[4-(4-amino-5-mercapto-4H-[1,2,4]triazol-3-yl)-phenyl]-3-trifluoromethyl-pyrazol1-yl}-benzenesulfonamide and their anti-inflammatory potential. Bioorg Chem 2019,91,103110","journal-title":"Bioorg Chem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1080\/14756366.2020.1791842","volume":"35","author":"Othman I.M.M.","year":"2020","unstructured":"Othman I.M.M.; Gad-Elkareem M.A.M.; Amr A.E.G.E.; Al-Omar M.A.; Nossier E.S.; Elsayed E.A.; Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase: design, biological evaluation and in silico studies. J Enzyme Inhib Med Chem 2020,35(1),1491-1502","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"112066","DOI":"10.1016\/j.ejmech.2020.112066","volume":"189","author":"Gedawy E.M.","year":"2020","unstructured":"Gedawy E.M.; Kassab A.E.; El Kerdawy A.M.; Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2\/5-LOX inhibitors. Eur J Med Chem 2020,189,112066","journal-title":"Eur J Med Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/molecules22030467","volume":"22","author":"Xu W.","year":"2017","unstructured":"Xu W.; Pan Y.; Wang H.; Li H.; Peng Q.; Wei D.; Chen C.; Zheng J.; Synthesis and evaluation of new pyrazoline derivatives as potential anticancer agents in HepG-2 cell line. Molecules 2017,22(3),467","journal-title":"Molecules"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1700026","DOI":"10.1002\/ardp.201700026","volume":"350","author":"Abd El Razik H.A.","year":"2017","unstructured":"Abd El Razik H.A.; Badr M.H.; Atta A.H.; Mouneir S.M.; Abu-Serie M.M.; Benzodioxole-pyrazole hybrids as antiinflammatory and analgesic agents with COX\u20101, 2\/5\u2010LOX inhibition and antioxidant potential. Arch Pharm (Weinheim) 2017,350(5),1700026","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.phrs.2015.12.025","volume":"104","author":"Qiu H.Y.","year":"2016","unstructured":"Qiu H.Y.; Wang P.F.; Li Z.; Ma J.T.; Wang X.M.; Yang Y.H.; Zhu H.L.; Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition. Pharmacol Res 2016,104,86-96","journal-title":"Pharmacol Res"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1700025","DOI":"10.1002\/ardp.201700025","volume":"350","author":"Faidallah H.M.","year":"2017","unstructured":"Faidallah H.M.; Rostom S.A.F.; Synthesis, anti\u2010inflammatory activity, and cOX\u20101\/2 inhibition profile of some novel non\u2010acidic polysubstituted pyrazoles and pyrano [2, 3\u2010c] pyrazoles. Arch Pharm (Weinheim) 2017,350(5),1700025","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","volume":"31","author":"Gul H.I.","year":"2016","unstructured":"Gul H.I.; Tugrak M.; Sakagami H.; Taslimi P.; Gulcin I.; Supuran C.T.; Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3 H -indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides. J Enzyme Inhib Med Chem 2016,31(6),1619-1624","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1181627","DOI":"10.1080\/14756366.2016.1181627","volume":"31","author":"Mete E.","year":"2016","unstructured":"Mete E.; Comez B.; Inci Gul H.; Gulcin I.; Supuran C.T.; Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides. J Enzyme Inhib Med Chem 2016,31(Suppl. 2),1181627","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.bmc.2018.12.031","volume":"27","author":"Wang Y.T.","year":"2019","unstructured":"Wang Y.T.; Shi T.Q.; Zhu H.L.; Liu C.H.; Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. Bioorg Med Chem 2019,27(3),502-515","journal-title":"Bioorg Med Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5267\/j.ccl.2019.5.001","volume":"8","author":"Variya H.H.","year":"2019","unstructured":"Variya H.H.; Panchal V.; Patel G.R.; Synthesis and characterization of 4-((5-bromo-1H-pyrazolo [3,4-b]pyridin-3-yl)amino)-N-(substituted)benzenesulfonamide as Antibacterial, and Antioxidant Candidates. Curr Chem Lett 2019,8(4),177-186","journal-title":"Curr Chem Lett"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.3390\/ijms21155221","volume":"21","author":"Gornowicz A.","year":"2020","unstructured":"Gornowicz A.; Szymanowska A.; Mojzych M.; Bielawski K.; Bielawska A.; The effect of novel 7-methyl-5-phenyl-pyrazolo [4, 3-e] tetrazolo [4, 5-b][1, 2, 4] triazine sulfonamide derivatives on apoptosis and autophagy in DLD-1 and HT-29 colon cancer cells. Int J Mol Sci 2020,21(15),5221","journal-title":"Int J Mol Sci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13065-018-0479-1","volume":"12","author":"Al-Blewi F.F.","year":"2018","unstructured":"Al-Blewi F.F.; Almehmadi M.A.; Aouad M.R.; Bardaweel S.K.; Sahu P.K.; Messali M.; Rezki N.; El Ashry E.S.H.; Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents. Chem Cent J 2018,12(1),110","journal-title":"Chem Cent J"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/jhet.3875","volume":"57","author":"Virk N.A.","year":"2020","unstructured":"Virk N.A.; Rehman A.; Abbasi M.A.; Siddiqui S.Z.; Iqbal J.; Rasool S.; Khan S.U.; Htar T.T.; Khalid H.; Laulloo S.J.; Ali Shah S.A.; Microwave\u2010assisted synthesis of triazole derivatives conjugated with piperidine as new anti\u2010enzymatic agents. J Heterocycl Chem 2020,57(3),1387-1402","journal-title":"J Heterocycl Chem"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.3390\/molecules25245924","volume":"25","author":"Balewski \u0141.","year":"2020","unstructured":"Balewski \u0141.; S\u0105czewski F.; Bednarski P.J.; Wolff L.; Nadworska A.; Gdaniec M.; Kornicka A.; Synthesis, structure and cytotoxicity testing of novel 7-(4, 5-dihydro-1Himidazol-2-yl)-2-aryl-6, 7-dihydro-2H-imidazo [2, 1-c][1, 2, 4] triazol-3 (5H)-imine derivatives. Molecules 2020,25(24),5924","journal-title":"Molecules"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s13738-019-01796-y","volume":"17","author":"Elgogary S.R.","year":"2020","unstructured":"Elgogary S.R.; Khidre R.E.; El-Telbani E.M.; Regioselective synthesis and evaluation of novel sulfonamide 1,2,3-triazole derivatives as antitumor agents. J Indian Chem Soc 2020,17(4),765-776","journal-title":"J Indian Chem Soc"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/14756366.2018.1513927","volume":"33","author":"El-Gazzar M.G.","year":"2018","unstructured":"El-Gazzar M.G.; Nafie N.H.; Nocentini A.; Ghorab M.M.; Heiba H.I.; Supuran C.T.; Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates. J Enzyme Inhib Med Chem 2018,33(1),1565-1574","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bioorg.2019.01.002","volume":"85","author":"Sharma V.","year":"2019","unstructured":"Sharma V.; Kumar R.; Bua S.; Supuran C.T.; Sharma P.K.; Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors. Bioorg Chem 2019,85,198-208","journal-title":"Bioorg Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1134\/S1068162019050108","volume":"45","author":"Siliveri S.","year":"2019","unstructured":"Siliveri S.; Shiva R.; Design, synthesis, molecular docking, ADMET studies, and biological evaluation of isoxazoline and pyrazoline incorporating 1,2,3-triazole benzene sulfonamides. Russ J Bioorg Chem 2019,45(5),381-390","journal-title":"Russ J Bioorg Chem"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"104133","DOI":"10.1016\/j.bioorg.2020.104133","volume":"103","author":"Rezki N.","year":"2020","unstructured":"Rezki N.; Almehmadi M.A.; Ihmaid S.; Shehata A.M.; Omar A.M.; Ahmed H.E.A.; Aouad M.R.; Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses. Bioorg Chem 2020,103,104133","journal-title":"Bioorg Chem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1016\/j.bmc.2017.09.042","volume":"25","author":"Marchiori M.F.","year":"2017","unstructured":"Marchiori M.F.; Riul T.B.; Oliveira Bortot L.; Andrade P.; Junqueira G.G.; Foca G.; Doti N.; Ruvo M.; Dias-Baruffi M.; Carvalho I.; Campo V.L.; Binding of triazolelinked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion. Bioorg Med Chem 2017,25(21),6049-6059","journal-title":"Bioorg Med Chem"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"111843","DOI":"10.1016\/j.ejmech.2019.111843","volume":"185","author":"Said M.A.","year":"2020","unstructured":"Said M.A.; Eldehna W.M.; Nocentini A.; Bonardi A.; Fahim S.H.; Bua S.; Soliman D.H.; Abdel-Aziz H.A.; Gratteri P.; Abou-Seri S.M.; Supuran C.T.; Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors. Eur J Med Chem 2020,185,111843","journal-title":"Eur J Med Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"103327","DOI":"10.1016\/j.bioorg.2019.103327","volume":"93","author":"Chamduang C.","year":"2019","unstructured":"Chamduang C.; Pingaew R.; Prachayasittikul V.; Prachayasittikul S.; Ruchirawat S.; Prachayasittikul V.; Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors. Bioorg Chem 2019,93,103327","journal-title":"Bioorg Chem"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/metabo10050200","volume":"10","author":"Chinchilli K.K.","year":"2020","unstructured":"Chinchilli K.K.; Angeli A.; Thacker P.S.; Korra L.N.; Biswas R.; Arifuddin M.; Supuran C.T.; Design, synthesis, and biological evaluation of 1,2,3-triazole-linked triazino[5,6-b]indole-benzene sulfonamide conjugates as potent carbonic anhydrase I, II, IX, and XIII inhibitors. Metabolites 2020,10(5),200","journal-title":"Metabolites"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10637-018-0632-7","volume":"36","author":"Guo S.","year":"2018","unstructured":"Guo S.; Zhen Y.; Guo M.; Zhang L.; Zhou G.; Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors. Invest New Drugs 2018,36(6),1147-1157","journal-title":"Invest New Drugs"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/cmdc.201700446","volume":"12","author":"Angapelly S.","year":"2017","unstructured":"Angapelly S.; Sri Ramya P.V.; Angeli A.; Supuran C.T.; Arifuddin M.; Sulfocoumarin-, coumarin-, 4-sulfamoylphenyl-bearing indazole-3-carboxamide hybrids: Synthesis and selective inhibition of tumor-associated carbonic anhydrase isozymes IX and XII. ChemMedChem 2017,12(19),1578-1584","journal-title":"ChemMedChem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1021\/acs.jmedchem.9b00664","volume":"63","author":"Yang J.","year":"2020","unstructured":"Yang J.; Shibu M.A.; Kong L.; Luo J.; BadrealamKhan F.; Huang Y.; Tu Z.C.; Yun C.H.; Huang C.Y.; Ding K.; Lu X.; BadrealamKhan F.; Huang Y.; Tu Z.-C.; Yun C.-H.; Huang C.-Y.; Ding K.; Lu X.; Design, synthesis, and structure-activity relationships of 1,2,3-triazole benzenesulfonamides as new selective leucine-zipper and sterile-\u03b1 motif kinase (ZAK) inhibitors. J Med Chem 2020,63(5),2114-2130","journal-title":"J Med Chem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"112439","DOI":"10.1016\/j.ejmech.2020.112439","volume":"200","author":"Elzahhar P.A.","year":"2020","unstructured":"Elzahhar P.A.; Abd El Wahab S.M.; Elagawany M.; Daabees H.; Belal A.S.F.; EL-Yazbi A.F.; Eid A.H.; Alaaeddine R.; Hegazy R.R.; Allam R.M.; Helmy M.W.; Bahaa Elgendy ; Angeli A.; El-Hawash S.A.; Supuran C.T.; Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases. Eur J Med Chem 2020,200,112439","journal-title":"Eur J Med Chem"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13065-018-0378-5","volume":"12","author":"Khalid W.","year":"2018","unstructured":"Khalid W.; Badshah A.; Khan A.; Nadeem H.; Ahmed S.; Synthesis, characterization, molecular docking evaluation, antiplatelet and anticoagulant actions of 1,2,4 triazole hydrazone and sulphonamide novel derivatives. Chem Cent J 2018,12(1),11","journal-title":"Chem Cent J"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1021\/acs.jmedchem.7b01826","volume":"61","author":"Focken T.","year":"2018","unstructured":"Focken T.; Chowdhury S.; Zenova A.; Grimwood M.E.; Chabot C.; Sheng T.; Hemeon I.; Decker S.M.; Wilson M.; Bichler P.; Jia Q.; Sun S.; Young C.; Lin S.; Goodchild S.J.; Shuart N.G.; Chang E.; Xie Z.; Li B.; Khakh K.; Bankar G.; Waldbrook M.; Kwan R.; Nelkenbrecher K.; Karimi Tari P.; Chahal N.; Sojo L.; Robinette C.L.; White A.D.; Chen C.A.; Zhang Y.; Pang J.; Chang J.H.; Hackos D.H.; Johnson J.P.; Cohen C.J.; Ortwine D.F.; Sutherlin D.P.; Dehnhardt C.M.; Safina B.S.; Design of conformationally constrained acyl sulfonamide isosteres: Identification of N-([1,2,4]triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as potent and selective hNaV1.7 inhibitors for the treatment of pain. J Med Chem 2018,61(11),4810-4831","journal-title":"J Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"112478","DOI":"10.1016\/j.ejmech.2020.112478","volume":"201","author":"Ceni C.","year":"2020","unstructured":"Ceni C.; Catarzi D.; Varano F.; Ben D.D.; Marucci G.; Buccioni M.; Volpini R.; Angeli A.; Nocentini A.; Gratteri P.; Supuran C.T.; Colotta V.; Discovery of first-inclass multi-target adenosine A2A receptor antagonistscarbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents. Eur J Med Chem 2020,201,112478","journal-title":"Eur J Med Chem"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/jhet.3888","volume":"57","author":"Batra N.","year":"2020","unstructured":"Batra N.; Rajendran V.; Wadi I.; Lathwal A.; Dutta R.K.; Ghosh P.C.; Gupta R.D.; Nath M.; Synthesis, characterization, and antiplasmodial efficacy of sulfonamideappended [1,2,3]\u2010triazoles. J Heterocycl Chem 2020,57(4),1625-1636","journal-title":"J Heterocycl Chem"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3184\/174751918X15161933697853","volume":"42","author":"Li N.","year":"2018","unstructured":"Li N.; Liu N.; Tang S.; Li D.L.; Zhang X.J.; Synthesis and antiproliferative activity of novel 1,2,3-triazolesulfonamide hybrids. J Chem Res 2018,42(1),50-53","journal-title":"J Chem Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1039\/D0MD00162G","volume":"11","author":"Manasa K.L.","year":"2020","unstructured":"Manasa K.L.; Thatikonda S.; Sigalapalli D.K.; Vuppaladadium S.; Devi G.P.; Godugu C.; Alvala M.; Nagesh N.; Babu B.N.; Design and synthesis of substituted (1-(benzyl)-1 H -1,2,3-triazol-4-yl)(piperazin-1-yl)methanone conjugates: study on their apoptosis inducing ability and tubulin polymerization inhibition. RSC Med Chem 2020,11(11),1295-1302","journal-title":"RSC Med Chem"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","volume":"63","author":"Berrino E.","year":"2020","unstructured":"Berrino E.; Angeli A.; Zhdanov D.D.; Kiryukhina A.P.; Milaneschi A.; De Luca A.; Bozdag M.; Carradori S.; Selleri S.; Bartolucci G.; Peat T.S.; Ferraroni M.; Supuran C.T.; Carta F.; Azidothymidine \u201cclicked\u201d into 1,2,3-triazoles: First report on carbonic anhydrase-telomerase dual-hybrid inhibitors. J Med Chem 2020,63(13),7392-7409","journal-title":"J Med Chem"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"103567","DOI":"10.1016\/j.bioorg.2020.103567","volume":"96","author":"Hamdani S.S.","year":"2020","unstructured":"Hamdani S.S.; Khan B.A.; Hameed S.; Batool F.; Saleem H.N.; Mughal E.U.; Saeed M.; Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease. Bioorg Chem 2020,96,103567","journal-title":"Bioorg Chem"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00706-016-1723-9","volume":"147","author":"Ajeesh Kumar A.K.","year":"2016","unstructured":"Ajeesh Kumar A.K.; Nair K.B.; Bodke Y.D.; Sambasivam G.; Bhat K.G.; Design, synthesis, and evaluation of the anticancer properties of a novel series of carboxamides, sulfonamides, ureas, and thioureas derived from 1,2,4-oxadiazol-3-ylmethyl-piperazin-1-yl substituted with pyrazolo[1,5-a]pyrimidine derivatives. Monatsh Chem 2016,147(12),2221-2234","journal-title":"Monatsh Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1016\/j.arabjc.2020.04.032","volume":"13","author":"Mohamed M.F.","year":"2020","unstructured":"Mohamed M.F.; Elhakim H.K.A.; Saddiq A.A.; Abdelhamid I.A.; A novel inhibitor, 2-cyano-3-(1-phenyl-3-(thiophen-2-yl)-pyrazol-4-yl)acrylamide linked to sulphamethoxazole, blocks anti-apoptotic proteins via molecular docking and strongly induced apoptosis of HCT116 cell line by different molecular tools. Arab J Chem 2020,13(7),5978-5995","journal-title":"Arab J Chem"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"103754","DOI":"10.1016\/j.bioorg.2020.103754","volume":"98","author":"Shamsi F.","year":"2020","unstructured":"Shamsi F.; Hasan P.; Queen A.; Hussain A.; Khan P.; Zeya B.; King H.M.; Rana S.; Garrison J.; Alajmi M.F.; Rizvi M.M.A.; Zahid M.; Imtaiyaz Hassan M.; Abid M.; Synthesis and SAR studies of novel 1,2,4-oxadiazolesulfonamide based compounds as potential anticancer agents for colorectal cancer therapy. Bioorg Chem 2020,98,103754","journal-title":"Bioorg Chem"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1016\/j.bmcl.2017.04.040","volume":"27","author":"Pero J.E.","year":"2017","unstructured":"Pero J.E.; Rossi M.A.; Lehman H.D.G.F.; Kelly M.J.; Mulhearn J.J.; Wolkenberg S.E.; Cato M.J.; Clements M.K.; Daley C.J.; Filzen T.; Finger E.N.; Gregan Y.; Henze D.A.; Jovanovska A.; Klein R.; Kraus R.L.; Li Y.; Liang A.; Majercak J.M.; Panigel J.; Urban M.O.; Wang J.; Wang Y.H.; Houghton A.K.; Layton M.E.; Benzoxazolinone aryl sulfonamides as potent, selective Na v 1.7 inhibitors with in vivo efficacy in a preclinical pain model. Bioorg Med Chem Lett 2017,27(12),2683-2688","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejmech.2018.12.049","volume":"164","author":"Krasavin M.","year":"2019","unstructured":"Krasavin M.; Shetnev A.; Sharonova T.; Baykov S.; Kalinin S.; Nocentini A.; Sharoyko V.; Poli G.; Tuccinardi T.; Presnukhina S.; Tennikova T.B.; Supuran C.T.; Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. Eur J Med Chem 2019,164,92-105","journal-title":"Eur J Med Chem"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/jhet.3647","volume":"56","year":"2019","unstructured":"\u00d6zkan, H.; Demirci, B. Synthesis and antimicrobial and antioxidant activities of sulfonamide derivatives containing tetrazole and oxadiazole rings. J Heterocycl Chem 2019,56(9),2528-2535","journal-title":"J Heterocycl Chem"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1002\/slct.202001449","volume":"5","author":"Dende S.K.","year":"2020","unstructured":"Dende S.K.; Korupolu R.B.; Leleti K.R.; Design and synthesis of sulfonamide-attached 2-(isoxazol-3-yl)-1Himidazoles as anticancer agents. ChemistrySelect 2020,5(26),7919-7922","journal-title":"ChemistrySelect"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/S1984-82502016000100009","volume":"52","author":"Sattar A.","year":"2016","unstructured":"Sattar A.; Aziz-ur-Rehman ; Abbasi M.A.; Siddiqui S.Z.; Rasool S.; Ahmad I.; Synthesis of some novel enzyme inhibitors and antibacterial agents derived from 5-(1-(4-tosyl)piperidin-4-yl)-1,3,4-oxadiazol-2-thiol. Braz J Pharm Sci 2016,52(1),77-85","journal-title":"Braz J Pharm Sci"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/ijms21062235","volume":"21","year":"2020","unstructured":"Szafra\u0144ski, K.; S\u0142awi\u0144ski, J.; Tomorowicz, \u0141.; Kawiak, A. Synthesis, anticancer evaluation and structure-activity analysis of novel (E)-5-(2-arylvinyl)-1, 3, 4-oxadiazol-2-yl) benzenesulfonamides. Int J Mol Sci 2020,21(6),2235","journal-title":"Int J Mol Sci"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.compbiolchem.2018.04.006","volume":"74","author":"Kachaeva M.V.","year":"2018","unstructured":"Kachaeva M.V.; Hodyna D.M.; Semenyuta I.V.; Pilyo S.G.; Prokopenko V.M.; Kovalishyn V.V.; Metelytsia L.O.; Brovarets V.S.; Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents. Comput Biol Chem 2018,74,294-303","journal-title":"Comput Biol Chem"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4172\/2161-0401.100016","volume":"5","author":"Vinoda B.","year":"2016","unstructured":"Vinoda B.; Bodke Y.; Vinuth M.; Sindhe M.; Venkatesh T.; Telkar S.; One pot synthesis, antimicrobial and in silico molecular docking study of 1, 3-benzoxazole-5-sulfonamide derivatives. Org Chem: Curr Res 2016,5,163","journal-title":"Org Chem: Curr Res"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1021\/acs.jmedchem.6b01851","volume":"60","author":"Weiss M.M.","year":"2017","unstructured":"Weiss M.M.; Dineen T.A.; Marx I.E.; Altmann S.; Boezio A.; Bregman H.; Chu-Moyer M.; DiMauro E.F.; Feric Bojic E.; Foti R.S.; Gao H.; Graceffa R.; Gunaydin H.; Guzman-Perez A.; Huang H.; Huang L.; Jarosh M.; Kornecook T.; Kreiman C.R.; Ligutti J.; La D.S.; Lin M.H.J.; Liu D.; Moyer B.D.; Nguyen H.N.; Peterson E.A.; Rose P.E.; Taborn K.; Youngblood B.D.; Yu V.; Fremeau R.T.; Sulfonamides as selective NaV1. 7 inhibitors: optimizing potency and pharmacokinetics while mitigating metabolic liabilities. J Med Chem 2017,60(14),5969-5989","journal-title":"J Med Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"115086","DOI":"10.1016\/j.bmc.2019.115086","volume":"27","author":"Kalinin S.","year":"2019","unstructured":"Kalinin S.; Valtari A.; Ruponen M.; Toropainen E.; Kovalenko A.; Nocentini A.; Gureev M.; Dar\u2019in D.; Urtti A.; Supuran C.T.; Krasavin M.; Highly hydrophilic 1,3-oxazol-5-yl benzenesulfonamide inhibitors of carbonic anhydrase II for reduction of glaucoma-related intraocular pressure. Bioorg Med Chem 2019,27(21),115086","journal-title":"Bioorg Med Chem"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.molstruc.2018.04.055","volume":"1167","author":"Sunil Kumar A.","year":"2018","unstructured":"Sunil Kumar A.; Kudva J.; Madan Kumar S.; Vishwanatha U.; Kumar V.; Naral D.; Synthesis, characterization, crystal structure, Hirshfeld interaction and bioevaluation studies of 4-amino quinazoline sulfonamide derivatives. J Mol Struct 2018,1167,142-153","journal-title":"J Mol Struct"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jscs.2015.01.004","volume":"20","author":"Desai N.C.","year":"2016","unstructured":"Desai N.C.; Makwana A.H.; Senta R.D.; Synthesis, characterization and antimicrobial activity of some novel 4-(4-(arylamino)-6-(piperidin-1-yl)-1,3,5-triazine-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamides. J Saudi Chem Soc 2016,20(6),686-694","journal-title":"J Saudi Chem Soc"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.3390\/ijms21082924","volume":"21","author":"Tomorowicz \u0141.","year":"2020","unstructured":"Tomorowicz \u0141.; S\u0142awi\u0144ski J.; \u017bo\u0142nowska B.; Szafra\u0144ski K.; Kawiak A.; Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of novel 2-[(4-amino-6-N-substituted-1, 3, 5-triazin-2-yl) methylthio]-4-chloro-5-methyl-N-(1H-benzo [d] imidazol-2 (3H)-ylidene) benzenesulfonamides. Int J Mol Sci 2020,21(8),2924","journal-title":"Int J Mol Sci"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3390\/molecules25081787","volume":"25","author":"Havr\u00e1nkov\u00e1 E.","year":"2020","unstructured":"Havr\u00e1nkov\u00e1 E.; \u010calkovsk\u00e1 N.; Padrtov\u00e1 T.; Cs\u00f6llei J.; Opat\u0159ilov\u00e1 R.; Pazdera P.; Antioxidative activity of 1, 3, 5-triazine analogues incorporating aminobenzene sulfonamide, aminoalcohol\/phenol, piperazine, chalcone, or stilbene motifs. Molecules 2020,25(8),1787","journal-title":"Molecules"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"115453","DOI":"10.1016\/j.bmc.2020.115453","volume":"28","author":"Kuriwaki I.","year":"2020","unstructured":"Kuriwaki I.; Kameda M.; Hisamichi H.; Kikuchi S.; Iikubo K.; Kawamoto Y.; Moritomo H.; Kondoh Y.; Amano Y.; Tateishi Y.; Echizen Y.; Iwai Y.; Noda A.; Tomiyama H.; Suzuki T.; Hirano M.; Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2. Bioorg Med Chem 2020,28(10),115453","journal-title":"Bioorg Med Chem"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/14756366.2016.1238362","volume":"32","author":"Mojzych M.","year":"2017","unstructured":"Mojzych M.; Tarasiuk P.; Kotwica-Mojzych K.; Rafiq M.; Seo S.Y.; Nicewicz M.; Fornal E.; Synthesis of chiral pyrazolo[4,3- e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity. J Enzyme Inhib Med Chem 2017,32(1),99-105","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14756366.2015.1024674","volume":"31","author":"Mojzych M.","year":"2015","unstructured":"Mojzych M.; Kubacka M.; Mogilski S.; Filipek B.; Fornal E.; Relaxant effects of selected sildenafil analogues in the rat aorta. J Enzyme Inhib Med Chem 2015,31(3),1-8","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/cbdd.12807","volume":"88","author":"Zheng X.Z.","year":"2016","unstructured":"Zheng X.Z.; Zhou J.L.; Ye J.; Guo P.P.; Lin C.S.; Cardioprotective effect of novel sulphonamides-1,3,5-triazine conjugates against ischaemic-reperfusion injury via selective inhibition of MMP-9. Chem Biol Drug Des 2016,88(5),756-765","journal-title":"Chem Biol Drug Des"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"83438","DOI":"10.1039\/C6RA15948F","volume":"6","author":"Gao H.D.","year":"2016","unstructured":"Gao H.D.; Liu P.; Yang Y.; Gao F.; Sulfonamide-1,3,5-triazine-thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4. RSC Advances 2016,6(86),83438-83447","journal-title":"RSC Advances"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1016\/j.bmc.2017.09.025","volume":"25","author":"Gamage S.A.","year":"2017","unstructured":"Gamage S.A.; Giddens A.C.; Tsang K.Y.; Flanagan J.U.; Kendall J.D.; Lee W.J.; Baguley B.C.; Buchanan C.M.; Jamieson S.M.F.; Shepherd P.R.; Denny W.A.; Rewcastle G.W.; Synthesis and biological evaluation of sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474. Bioorg Med Chem 2017,25(20),5859-5874","journal-title":"Bioorg Med Chem"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2174\/1573409916666201224152253","volume":"17","author":"Daoud S.","year":"2021","unstructured":"Daoud S.; Taha M.O.; Design and synthesis of new JAK1 inhibitors based on sulfonamide-triazine conjugates. Curr. Comput.-. Curr Computeraided Drug Des 2021,17(7),916-926","journal-title":"Curr Computeraided Drug Des"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/molecules21020189","volume":"21","author":"Ghorab M.","year":"2016","unstructured":"Ghorab M.; Alsaid M.; Al-Dosari M.; El-Gazzar M.; Parvez M.; Design, synthesis and anticancer evaluation of novel quinazoline-sulfonamide hybrids. Molecules 2016,21(2),189","journal-title":"Molecules"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/14756366.2017.1334650","volume":"32","author":"Ghorab M.M.","year":"2017","unstructured":"Ghorab M.M.; Alsaid M.S.; Soliman A.M.; Ragab F.A.; VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo [g] quinazolin bearing benzenesulfonamide moiety. J Enzyme Inhib Med Chem 2017,32(1),893-907","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/14756366.2019.1609469","volume":"34","author":"Soliman A.M.","year":"2019","unstructured":"Soliman A.M.; Alqahtani A.S.; Ghorab M.M.; Novel sulfonamide benzoquinazolinones as dual EGFR\/HER2 inhibitors, apoptosis inducers and radiosensitizers. J Enzyme Inhib Med Chem 2019,34(1),1030-1040","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"112333","DOI":"10.1016\/j.ejmech.2020.112333","volume":"197","author":"Soliman A.M.","year":"2020","unstructured":"Soliman A.M.; Karam H.M.; Mekkawy M.H.; Ghorab M.M.; Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-\u03baB\/PON1 pathway. Eur J Med Chem 2020,197,112333","journal-title":"Eur J Med Chem"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"13586","DOI":"10.1002\/slct.201802402","volume":"3","author":"Kumar A.S.","year":"2018","unstructured":"Kumar A.S.; Kudva J.; Bharath B.R.; Rai V.M.; Kumar S.M.; Kumar V.; Sajankila S.P.; Synthesis, characterization, molecular docking studies and biological evaluation of some conjugated quinazoline-sulfonamide scaffold. ChemistrySelect 2018,3(48),13586-13595","journal-title":"ChemistrySelect"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.molstruc.2018.12.098","volume":"1181","author":"Venkatesh R.","year":"2019","unstructured":"Venkatesh R.; Kasaboina S.; Jain N.; Janardhan S.; Holagunda U.D.; Nagarapu L.; Design and synthesis of novel sulphamide tethered quinazolinone hybrids as potential antitumor agents. J Mol Struct 2019,1181,403-411","journal-title":"J Mol Struct"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.1021\/acs.jmedchem.8b01407","volume":"61","author":"Waszkowycz B.","year":"2018","unstructured":"Waszkowycz B.; Smith K.M.; McGonagle A.E.; Jordan A.M.; Acton B.; Fairweather E.E.; Griffiths L.A.; Hamilton N.M.; Hamilton N.S.; Hitchin J.R.; Hutton C.P.; James D.I.; Jones C.D.; Jones S.; Mould D.P.; Small H.F.; Stowell A.I.J.; Tucker J.A.; Waddell I.D.; Ogilvie D.J.; Cell-active small molecule inhibitors of the DNAdamage repair enzyme poly(ADP-ribose) glycohydrolase (PARG): Discovery and optimization of orally bioavailable quinazolinedione sulfonamides. J Med Chem 2018,61(23),10767-10792","journal-title":"J Med Chem"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1021\/acsmedchemlett.6b00243","volume":"7","author":"Marx I.E.","year":"2016","unstructured":"Marx I.E.; Dineen T.A.; Able J.; Bode C.; Bregman H.; Chu-Moyer M.; DiMauro E.F.; Du B.; Foti R.S.; Fremeau R.T.; Gao H.; Gunaydin H.; Hall B.E.; Huang L.; Kornecook T.; Kreiman C.R.; La D.S.; Ligutti J.; Lin M.H.J.; Liu D.; McDermott J.S.; Moyer B.D.; Peterson E.A.; Roberts J.T.; Rose P.; Wang J.; Youngblood B.D.; Yu V.; Weiss M.M.; Sulfonamides as selective Na V 1.7 inhibitors: Optimizing potency and pharmacokinetics to enable in vivo target engagement. ACS Med Chem Lett 2016,7(12),1062-1067","journal-title":"ACS Med Chem Lett"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bioorg.2017.12.035","volume":"77","author":"Aday B.","year":"2018","unstructured":"Aday B.; Ulus R.; Tan\u00e7 M.; Kaya M.; Supuran C.T.; Synthesis of novel 5-amino-1,3,4-thiadiazole-2-sulfonamide containing acridine sulfonamide\/carboxamide compounds and investigation of their inhibition effects on human carbonic anhydrase I, II, IV and VII. Bioorg Chem 2018,77,101-105","journal-title":"Bioorg Chem"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1016\/j.bmcl.2016.07.006","volume":"26","author":"Zhao Y.","year":"2016","unstructured":"Zhao Y.; Shadrick W.R.; Wallace M.J.; Wu Y.; Griffith E.C.; Qi J.; Yun M.K.; White S.W.; Lee R.E.; Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents. Bioorg Med Chem Lett 2016,26(16),3950-3954","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bioorg.2016.07.006","volume":"68","author":"Mert S.","year":"2016","unstructured":"Mert S.; Al\u0131m Z.; \u0130\u015fg\u00f6r M.M.; Beydemir \u015e.; Kas\u0131mo\u011fullar\u0131 R.; The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II. Bioorg Chem 2016,68,64-71","journal-title":"Bioorg Chem"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1016\/j.arabjc.2016.09.015","volume":"12","author":"Charitos G.","year":"2019","unstructured":"Charitos G.; Trafalis D.T.; Dalezis P.; Potamitis C.; Sarli V.; Zoumpoulakis P.; Camoutsis C.; Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. Arab J Chem 2019,12(8),4784-4794","journal-title":"Arab J Chem"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/acsmedchemlett.5b00447","volume":"7","author":"Focken T.","year":"2016","unstructured":"Focken T.; Liu S.; Chahal N.; Dauphinais M.; Grimwood M.E.; Chowdhury S.; Hemeon I.; Bichler P.; Bogucki D.; Waldbrook M.; Bankar G.; Sojo L.E.; Young C.; Lin S.; Shuart N.; Kwan R.; Pang J.; Chang J.H.; Safina B.S.; Sutherlin D.P.; Johnson J.P.; Jr.; Dehnhardt, C.M.; Mansour, T.S.; Oballa, R.M.; Cohen, C.J.; Robinette, C.L. Discovery of aryl sulfonamides as isoform-selective inhibitors of NaV1.7 with efficacy in rodent pain models. ACS Med Chem Lett 2016,7(3),277-282","journal-title":"ACS Med Chem Lett"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"2000094","DOI":"10.1002\/ardp.202000094","volume":"353","author":"El-Hazek R.M.M.","year":"2020","unstructured":"El-Hazek R.M.M.; El-Sabbagh W.A.; El-Hazek R.M.; El-Gazzar M.G.; Anti\u2010inflammatory and analgesic effect of LD\u2010RT and some novel thiadiazole derivatives through COX\u20102 inhibition. Arch Pharm (Weinheim) 2020,353(10),2000094","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.bmc.2016.12.047","volume":"25","author":"Kumar R.","year":"2017","unstructured":"Kumar R.; Bua S.; Ram S.; Del Prete S.; Capasso C.; Supuran C.T.; Sharma P.K.; Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors. Bioorg Med Chem 2017,25(3),1286-1293","journal-title":"Bioorg Med Chem"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ejmech.2017.04.028","volume":"134","author":"Ghorab M.M.","year":"2017","unstructured":"Ghorab M.M.; Alsaid M.S.; Samir N.; Abdel-Latif G.A.; Soliman A.M.; Ragab F.A.; Abou El Ella D.A.; Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules. Eur J Med Chem 2017,134,304-315","journal-title":"Eur J Med Chem"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molstruc.2019.03.010","volume":"1186","author":"G\u00fcnd\u00fcz M.G.","year":"2019","unstructured":"G\u00fcnd\u00fcz M.G.; Tahir M.N.; Armakovi\u0107 S.; \u00d6zkul Ko\u00e7ak C.; Armakovi\u0107 S.J.; Design, synthesis and computational analysis of novel acridine-(sulfadiazine\/sulfathiazole) hybrids as antibacterial agents. J Mol Struct 2019,1186,39-49","journal-title":"J Mol Struct"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1080\/14756366.2019.1639696","volume":"34","author":"Liu J.","year":"2019","unstructured":"Liu J.; Liu C.; Zhang X.; Yu L.; Gong X.; Wang P.; Anticancer sulfonamide hybrids that inhibit bladder cancer cells growth and migration as tubulin polymerisation inhibitors. J Enzyme Inhib Med Chem 2019,34(1),1380-1387","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bmcl.2016.11.028","volume":"27","year":"2017","unstructured":"Esirden, \u0130.; Tan\u00e7, M.; Supuran, C.T.; Kaya, M. Microwave assisted synthesis of novel tetrazole\/sulfonamide derivatives based on octahydroacridine, xanthene and chromene skeletons as inhibitors of the carbonic anhydrases isoforms I, II, IV and VII. Bioorg Med Chem Lett 2017,27(1),86-89","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/acsinfecdis.6b00103","volume":"3","author":"Park Y.","year":"2017","unstructured":"Park Y.; Pacitto A.; Bayliss T.; Cleghorn L.A.T.; Wang Z.; Hartman T.; Arora K.; Ioerger T.R.; Sacchettini J.; Rizzi M.; Donini S.; Blundell T.L.; Ascher D.B.; Rhee K.; Breda A.; Zhou N.; Dartois V.; Jonnala S.R.; Via L.E.; Mizrahi V.; Epemolu O.; Stojanovski L.; Simeons F.; Osuna-Cabello M.; Ellis L.; MacKenzie C.J.; Smith A.R.C.; Davis S.H.; Murugesan D.; Buchanan K.I.; Turner P.A.; Huggett M.; Zuccotto F.; Rebollo-Lopez M.J.; Lafuente-Monasterio M.J.; Sanz O.; Diaz G.S.; Leli\u00e8vre J.; Ballell L.; Selenski C.; Axtman M.; Ghidelli-Disse S.; Pflaumer H.; B\u00f6sche M.; Drewes G.; Freiberg G.M.; Kurnick M.D.; Srikumaran M.; Kempf D.J.; Green S.R.; Ray P.C.; Read K.; Wyatt P.; Barry C.E.; Boshoff H.I.; Essential but not vulnerable: indazole sulfonamides targeting inosine monophosphate dehydrogenase as potential leads against Mycobacterium tuberculosis. ACS Infect Dis 2017,3(1),18-33","journal-title":"ACS Infect Dis"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1021\/acs.jmedchem.8b00670","volume":"61","author":"Salerno S.","year":"2018","unstructured":"Salerno S.; Barresi E.; Amendola G.; Berrino E.; Milite C.; Marini A.M.; Da Settimo F.; Novellino E.; Supuran C.T.; Cosconati S.; Taliani S.; 4-Substituted benzenesulfonamides incorporating bi\/tricyclic moieties act as potent and isoform-selective carbonic anhydrase ii\/ix inhibitors. J Med Chem 2018,61(13),5765-5770","journal-title":"J Med Chem"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1021\/acs.molpharmaceut.8b01021","volume":"16","author":"Hu Y.Y.","year":"2019","unstructured":"Hu Y.Y.; Yadav Bheemanaboina R.R.; Battini N.; Zhou C.H.; Sulfonamide-derived four-component molecular hybrids as novel DNA-targeting membrane active potentiators against clinical Escherichia coli. Mol Pharm 2019,16(3),1036-1052","journal-title":"Mol Pharm"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"103725","DOI":"10.1016\/j.bioorg.2020.103725","volume":"98","author":"Halawa A.H.","year":"2020","unstructured":"Halawa A.H.; Elgammal W.E.; Hassan S.M.; Hassan A.H.; Nassar H.S.; Ebrahim H.Y.; Mehany A.B.M.; El-Agrody A.M.; Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons. Bioorg Chem 2020,98,103725","journal-title":"Bioorg Chem"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1134\/S1068162020030048","volume":"46","author":"Bonakdar A.P.S.","year":"2020","unstructured":"Bonakdar A.P.S.; Sadeghi A.; Aghaei H.R.; Beheshtimaal K.; Nazifi S.M.R.; Massah A.R.; Convenient synthesis of novel chalcone and pyrazoline sulfonamide derivatives as potential antibacterial agents. Russ J Bioorg Chem 2020,46(3),371-381","journal-title":"Russ J Bioorg Chem"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejmech.2019.05.013","volume":"176","author":"Casta\u00f1o L.F.","year":"2019","unstructured":"Casta\u00f1o L.F.; Cuartas V.; Bernal A.; Insuasty A.; Guzman J.; Vidal O.; Rubio V.; Puerto G.; Luk\u00e1\u010d P.; Vimberg V.; Bal\u00edkov\u00e1-Novton\u00e1 G.; Vannucci L.; Janata J.; Quiroga J.; Abonia R.; Nogueras M.; Cobo J.; Insuasty B.; New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity. Eur J Med Chem 2019,176,50-60","journal-title":"Eur J Med Chem"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/slct.201600286","volume":"1","author":"Suresh A.","year":"2016","unstructured":"Suresh A.; Suresh N.; Misra S.; Kumar M.M.K.; Sekhar K.V.G.C.; Design, synthesis and biological evaluation of new substituted sulfonamide tetrazole derivatives as antitubercular agents. ChemistrySelect 2016,1(8),1705-1710","journal-title":"ChemistrySelect"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bioorg.2017.01.003","volume":"70","author":"Ejaz S.A.","year":"2017","unstructured":"Ejaz S.A.; Saeed A.; Siddique M.N.; Nisa Z.; Khan S.; Lecka J.; S\u00e9vigny J.; Iqbal J.; Synthesis, characterization and biological evaluation of novel chalcone sulfonamide hybrids as potent intestinal alkaline phosphatase inhibitors. Bioorg Chem 2017,70,229-236","journal-title":"Bioorg Chem"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bioorg.2017.01.005","volume":"70","author":"Ulus R.","year":"2017","unstructured":"Ulus R.; Zengin Kurt B.; Gazio\u011flu I.; Kaya M.; Microwave assisted synthesis of novel hybrid tacrine-sulfonamide derivatives and investigation of their antioxidant and anticholinesterase activities. Bioorg Chem 2017,70,245-255","journal-title":"Bioorg Chem"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/10426507.2017.1417292","volume":"193","author":"Dalloul H.M.M.","year":"2018","unstructured":"Dalloul H.M.M.; El-Nwairy K.A.; Shorafa A.Z.; Abu Samaha A.S.; Synthesis and antimicrobial activities evaluation of some new thiadiazinone and thiadiazepinone derivatives bearing sulfonamide moiety. Phosphorus Sulfur Silicon Relat Elem 2018,193(5),288-293","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1016\/j.bmc.2018.07.042","volume":"26","author":"Okolotowicz K.J.","year":"2018","unstructured":"Okolotowicz K.J.; Dwyer M.; Ryan D.; Cheng J.; Cashman E.A.; Moore S.; Mercola M.; Cashman J.R.; Novel tertiary sulfonamides as potent anti-cancer agents. Bioorg Med Chem 2018,26(15),4441-4451","journal-title":"Bioorg Med Chem"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpddr.2017.01.003","volume":"7","author":"Fisher G.M.","year":"2017","unstructured":"Fisher G.M.; Bua S.; Del Prete S.; Arnold M.S.J.; Capasso C.; Supuran C.T.; Andrews K.T.; Poulsen S.A.; Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data. Int J Parasitol Drugs Drug Resist 2017,7(1),61-70","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1080\/14756366.2020.1809388","volume":"35","author":"Firoozpour L.","year":"2020","unstructured":"Firoozpour L.; Gao L.; Moghimi S.; Pasalar P.; Davoodi J.; Wang M.W.; Rezaei Z.; Dadgar A.; Yahyavi H.; Amanlou M.; Foroumadi A.; Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors. J Enzyme Inhib Med Chem 2020,35(1),1674-1684","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","volume":"139","author":"Eldehna W.M.","year":"2017","unstructured":"Eldehna W.M.; Abo-Ashour M.F.; Nocentini A.; Gratteri P.; Eissa I.H.; Fares M.; Ismael O.E.; Ghabbour H.A.; Elaasser M.M.; Abdel-Aziz H.A.; Supuran C.T.; Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies. Eur J Med Chem 2017,139,250-262","journal-title":"Eur J Med Chem"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00044-016-1741-5","volume":"26","author":"Rutkauskas K.","year":"2017","unstructured":"Rutkauskas K.; Zubrien\u0117 A.; Tumosien\u0117 I.; Kantminien\u0117 K.; Mickevi\u010dius V.; Matulis D.; Benzenesulfonamides bearing pyrrolidinone moiety as inhibitors of carbonic anhydrase IX: synthesis and binding studies. Med Chem Res 2017,26(1),235-246","journal-title":"Med Chem Res"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/ijms19051482","volume":"19","year":"2018","unstructured":"\u017bo\u0142nowska, B.; S\u0142awi\u0144ski, J.; Brzozowski, Z.; Kawiak, A.;  Belka, M.; Zieli\u0144ska, J.; B\u0105czek, T.; Chojnacki, J. Synthesis, molecular structure, anticancer activity, and QSAR  Study of N-(aryl\/heteroaryl)-4-(1H-pyrrol-1-yl) benzenesulfonamide derivatives. Int J Mol Sci 2018,19(5),1482","journal-title":"Int J Mol Sci"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bmcl.2016.11.068","volume":"27","author":"Sun L.","year":"2017","unstructured":"Sun L.; Wu Y.; Liu Y.; Chen X.; Hu L.; Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility. Bioorg Med Chem Lett 2017,27(2),261-265","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bioorg.2018.09.007","volume":"81","author":"Eldehna W.M.","year":"2018","unstructured":"Eldehna W.M.; Nocentini A.; Al-Rashood S.T.; Hassan G.S.; Alkahtani H.M.; Almehizia A.A.; Reda A.M.; Abdel-Aziz H.A.; Supuran C.T.; Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer. Bioorg Chem 2018,81,425-432","journal-title":"Bioorg Chem"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1016\/j.bmcl.2017.05.042","volume":"27","author":"Bender A.M.","year":"2017","unstructured":"Bender A.M.; Weiner R.L.; Luscombe V.B.; Ajmera S.; Cho H.P.; Chang S.; Zhan X.; Rodriguez A.L.; Niswender C.M.; Engers D.W.; Bridges T.M.; Conn P.J.; Lindsley C.W.; Discovery and optimization of 3-(4-aryl\/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists. Bioorg Med Chem Lett 2017,27(15),3576-3581","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/md15110343","volume":"15","author":"Wang L.J.","year":"2017","unstructured":"Wang L.J.; Guo C.L.; Li X.Q.; Wang S.Y.; Jiang B.; Zhao Y.; Luo J.; Xu K.; Liu H.; Guo S.J.; Wu N.; Shi D.Y.; Discovery of novel bromophenol hybrids as potential anticancer agents through the ROS-mediated apoptotic pathway: Design, synthesis and biological evaluation. Mar Drugs 2017,15(11),343","journal-title":"Mar Drugs"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"e22306","DOI":"10.1002\/jbt.22306","volume":"33","author":"Rifati-Nixha A.","year":"2019","unstructured":"Rifati-Nixha A.; Arslan M.; Gen\u00e7er N.; \u00c7\u0131kr\u0131k\u0131\u00e7\u0131 K.; G\u00f6k\u00e7e B.; Arslan O.; Synthesis of carbazole bearing pyridopyrimidine\u2010substituted sulfonamide derivatives and studies their carbonic anhydrase enzyme activity. J Biochem Mol Toxicol 2019,33(6),e22306","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.bmcl.2018.04.042","volume":"28","author":"Zhou D.","year":"2018","unstructured":"Zhou D.; Xie D.; He F.; Song B.; Hu D.; Antiviral properties and interaction of novel chalcone derivatives containing a purine and benzenesulfonamide moiety. Bioorg Med Chem Lett 2018,28(11),2091-2097","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bmcl.2018.12.034","volume":"29","author":"Boutard N.","year":"2019","unstructured":"Boutard N.; Bia\u0142as A.; Sabiniarz A.; Guzik P.; Banaszak K.; Biela A.; Bie\u0144 M.; Buda A.; Bugaj B.; Cieluch E.; Cierpich A.; Dudek \u0141.; Eggenweiler H.M.; Fogt J.; Gaik M.; Gondela A.; Jakubiec K.; Jurzak M.; Kitli\u0144ska A.; Kowalczyk P.; Kujawa M.; Kwieci\u0144ska K.; Le\u015b M.; Lindemann R.; Maciuszek M.; Mikulski M.; Niedziejko P.; Obara A.; Pawlik H.; Rzymski T.; Sieprawska-Lupa M.; Sowi\u0144ska M.; Szeremeta-Spisak J.; Stachowicz A.; Tomczyk M.M.; Wiklik K.; W\u0142oszczak \u0141.; Ziemia\u0144ska S.; Zar\u0119bski A.; Brz\u00f3zka K.; Nowak M.; Fabritius C.H.; Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties. Bioorg Med Chem Lett 2019,29(4),646-653","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/acs.jmedchem.6b01496","volume":"60","author":"Bregman H.","year":"2017","unstructured":"Bregman H.; Simard J.R.; Andrews K.L.; Ayube S.; Chen H.; Gunaydin H.; Guzman-Perez A.; Hu J.; Huang L.; Huang X.; Krolikowski P.H.; Lehto S.G.; Lewis R.T.; Michelsen K.; Pegman P.; Plant M.H.; Shaffer P.L.; Teffera Y.; Yi S.; Zhang M.; Gingras J.; DiMauro E.F.; The discovery and hit-to-lead optimization of tricyclic sulfonamides as potent and efficacious potentiators of glycine receptors. J Med Chem 2017,60(3),1105-1125","journal-title":"J Med Chem"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1021\/acs.jmedchem.9b00141","volume":"62","author":"McKerrall S.J.","year":"2019","unstructured":"McKerrall S.J.; Nguyen T.; Lai K.W.; Bergeron P.; Deng L.; DiPasquale A.; Chang J.H.; Chen J.; Chernov-Rogan T.; Hackos D.H.; Maher J.; Ortwine D.F.; Pang J.; Payandeh J.; Proctor W.R.; Shields S.D.; Vogt J.; Ji P.; Liu W.; Ballini E.; Schumann L.; Tarozzo G.; Bankar G.; Chowdhury S.; Hasan A.; Johnson J.P.; Khakh K.; Lin S.; Cohen C.J.; Dehnhardt C.M.; Safina B.S.; Sutherlin D.P.; Structure- and ligand-based discovery of chromane arylsulfonamide Nav1.7 inhibitors for the treatment of chronic pain. J Med Chem 2019,62(8),4091-4109","journal-title":"J Med Chem"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bmcl.2017.11.026","volume":"28","author":"Pandit S.S.","year":"2018","unstructured":"Pandit S.S.; Kulkarni M.R.; Pandit Y.B.; Lad N.P.; Khedkar V.M.; Synthesis and in vitro evaluations of 6-(hetero)-aryl-imidazo[1,2-b]pyridazine-3-sulfonamide\u2019s as an inhibitor of TNF-\u03b1 production. Bioorg Med Chem Lett 2018,28(1),24-30","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.bmcl.2017.02.066","volume":"27","author":"Zhu G.X.","year":"2017","unstructured":"Zhu G.X.; Cheng P.L.; Goto M.; Zhang N.; Morris-Natschke S.L.; Hsieh K.Y.; Yang G.Z.; Yang Q.R.; Liu Y.Q.; Chen H.L.; Zhang X.S.; Lee K.H.; Design, synthesis and potent cytotoxic activity of novel 7-(N -[(substituted-sulfonyl)piperazinyl]-methyl)-camptothecin derivatives. Bioorg Med Chem Lett 2017,27(8),1750-1753","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1080\/10406638.2019.1684326","volume":"41","author":"Bakhotmah D.A.","year":"2021","unstructured":"Bakhotmah D.A.; Al-Ahmadi A.A.; Design and synthesis of some new 3-oxo\/thioxo-1,2,4-triazolo[4,3-a] benzimidazole derivatives bearing a 4-tollyl sulfonyl moiety as antimycobacterial agents. Polycycl Aromat Compd 2021,41(7),1459-1471","journal-title":"Polycycl Aromat Compd"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1007\/s11164-017-3023-3","volume":"43","author":"Nie L.F.","year":"2017","unstructured":"Nie L.F.; Bozorov K.; Niu C.; Huang G.; Aisa H.A.; Synthesis and biological evaluation of novel sulfonamide derivatives of tricyclic thieno[2,3-d]pyrimidin-4(3H)-ones on melanin synthesis in murine B16 cells. Res Chem Intermed 2017,43(12),6835-6843","journal-title":"Res Chem Intermed"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00044-017-1850-9","volume":"26","author":"Ahmed N.S.","year":"2017","unstructured":"Ahmed N.S.; Badahdah K.O.; Qassar H.M.; Novel quinoline bearing sulfonamide derivatives and their cytotoxic activity against MCF7 cell line. Med Chem Res 2017,26(6),1201-1212","journal-title":"Med Chem Res"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"112181","DOI":"10.1016\/j.ejmech.2020.112181","volume":"191","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Wu Y.; Sun ; Gu Y.; Hu L.; Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents. Eur J Med Chem 2020,191,112181","journal-title":"Eur J Med Chem"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1016\/j.bmcl.2016.04.078","volume":"26","author":"Di Matteo M.","year":"2016","unstructured":"Di Matteo M.; Ammazzalorso A.; Andreoli F.; Caffa I.; De Filippis B.; Fantacuzzi M.; Giampietro L.; Maccallini C.; Nencioni A.; Parenti M.D.; Soncini D.; Del Rio A.; Amoroso R.; Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors. Bioorg Med Chem Lett 2016,26(13),3192-3194","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666221128142730","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211307\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666221128142730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T20:04:01Z","timestamp":1693685041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211307\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":244,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666221128142730","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}